<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN""http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"><html><head><title>Patent US6716251 - Implant for subcutaneous or intradermal injection - Google Patents</title><script>(function(){(function(){function e(a){this.t={};this.tick=function(a,c,b){var d=void 0!=b?b:(new Date).getTime();this.t[a]=[d,c];if(void 0==b)try{window.console.timeStamp("CSI/"+a)}catch(e){}};this.tick("start",null,a)}var a;window.performance&&(a=window.performance.timing);var f=a?new e(a.responseStart):new e;window.jstiming={Timer:e,load:f};if(a){var c=a.navigationStart,d=a.responseStart;0<c&&d>=c&&(window.jstiming.srt=d-c)}if(a){var b=window.jstiming.load;0<c&&d>=c&&(b.tick("_wtsrt",void 0,c),b.tick("wtsrt_",
"_wtsrt",d),b.tick("tbsd_","wtsrt_"))}try{a=null,window.chrome&&window.chrome.csi&&(a=Math.floor(window.chrome.csi().pageT),b&&0<c&&(b.tick("_tbnd",void 0,window.chrome.csi().startE),b.tick("tbnd_","_tbnd",c))),null==a&&window.gtbExternal&&(a=window.gtbExternal.pageT()),null==a&&window.external&&(a=window.external.pageT,b&&0<c&&(b.tick("_tbnd",void 0,window.external.startE),b.tick("tbnd_","_tbnd",c))),a&&(window.jstiming.pt=a)}catch(g){}})();})();
</script><link rel="stylesheet" href="/patents/css/_8a2b04e7bf975d5171d8e4c0b6365c7a/kl_intl_patents_bundle.css" type="text/css" /><script src="/books/javascript/atb_8a2b04e7bf975d5171d8e4c0b6365c7a__en.js"></script><script>function googleTranslateElementInit() {new google.translate.TranslateElement({pageLanguage: "en",gaTrack: true,gaId: "UA-27188110-1",multilanguagePage: true});}</script><script src="//translate.google.com/translate_a/element.js?cb=googleTranslateElementInit"></script><meta name="DC.type" content="Patent"><meta name="DC.title" content="Implant for subcutaneous or intradermal injection"><meta name="DC.contributor" content="Jérôme Asius" scheme="inventor"><meta name="DC.contributor" content="Hatem Fessi" scheme="inventor"><meta name="DC.contributor" content="Franck Gouchet" scheme="inventor"><meta name="DC.contributor" content="Bénédicte Laglenne" scheme="inventor"><meta name="DC.contributor" content="Elisabeth Laugier-Laglenne" scheme="inventor"><meta name="DC.contributor" content="Aventis Pharmaceuticals Holdings, Inc." scheme="assignee"><meta name="DC.date" content="1998-6-12" scheme="dateSubmitted"><meta name="DC.description" content="The invention concerns an injection implant for filling up wrinkles, thin lines, skin cracks and scars, for reparative or plastic surgery, aesthetic dermatology, and for filling up gums in dental treatment. The invention concerns the use of biologically absorbable polymer microspheres or microparticles suspended in a gel. Said suspension is produced either ready-for-use or freeze-dried. The biological absorbability of the microspheres is controlled and enables the production of implants having well defined persistence and deliberately limited to 3 years."><meta name="DC.date" content="2004-4-6" scheme="issued"><meta name="DC.relation" content="EP:0251695:A2" scheme="references"><meta name="DC.relation" content="EP:0648480:A2" scheme="references"><meta name="DC.relation" content="EP:0711548:A1" scheme="references"><meta name="DC.relation" content="FR:2778847" scheme="references"><meta name="DC.relation" content="US:4093576" scheme="references"><meta name="DC.relation" content="US:4897267" scheme="references"><meta name="DC.relation" content="US:4919929" scheme="references"><meta name="DC.relation" content="US:5059123" scheme="references"><meta name="DC.relation" content="US:5185152" scheme="references"><meta name="DC.relation" content="US:5258028" scheme="references"><meta name="DC.relation" content="US:5288496" scheme="references"><meta name="DC.relation" content="US:5344452" scheme="references"><meta name="DC.relation" content="US:5356629" scheme="references"><meta name="DC.relation" content="US:5451406" scheme="references"><meta name="DC.relation" content="US:5466462" scheme="references"><meta name="DC.relation" content="US:5470582" scheme="references"><meta name="DC.relation" content="US:5478837" scheme="references"><meta name="DC.relation" content="US:5597897" scheme="references"><meta name="DC.relation" content="US:5599852" scheme="references"><meta name="DC.relation" content="US:5977204" scheme="references"><meta name="DC.relation" content="WO:1993013755:A1" scheme="references"><meta name="DC.relation" content="WO:1993015721:A1" scheme="references"><meta name="DC.relation" content="WO:1996033751:A1" scheme="references"><meta name="DC.relation" content="WO:1999011196:A1" scheme="references"><meta name="citation_reference" content="Beising et al. &quot;Mammalian Response to Subdermal Implantaion of Textured Microimplants,&quot; Aesth. Plast. Surg. pp. 83-90, 1992.*"><meta name="citation_reference" content="Costantino et al., &quot;Soft-Tissue Augmentation and Replacement in the Head and Neck,&quot; Otolaryngologic Clinics of N.A., pp. 3,9,11, 1994.*"><meta name="citation_reference" content="Ersek et al. &quot;Bioplastique: A New Biphasic Polymer for Minimally Invasive Injection Implantation,&quot; Aesth. Plast. Surg. , pp. 59-65, 1992.*"><meta name="citation_reference" content="Tom et al, Biotechnol. Prog. (1991), 7 (5), 403-411, (Abstract only)."><meta name="citation_patent_number" content="US:6716251"><meta name="citation_patent_application_number" content="US:09/242,103"><link rel="canonical" href="http://www.google.com/patents/US6716251"/><meta property="og:url" content="http://www.google.com/patents/US6716251"/><meta name="title" content="Patent US6716251 - Implant for subcutaneous or intradermal injection"/><meta name="description" content="The invention concerns an injection implant for filling up wrinkles, thin lines, skin cracks and scars, for reparative or plastic surgery, aesthetic dermatology, and for filling up gums in dental treatment. The invention concerns the use of biologically absorbable polymer microspheres or microparticles suspended in a gel. Said suspension is produced either ready-for-use or freeze-dried. The biological absorbability of the microspheres is controlled and enables the production of implants having well defined persistence and deliberately limited to 3 years."/><meta property="og:title" content="Patent US6716251 - Implant for subcutaneous or intradermal injection"/><meta property="og:type" content="book"/><meta property="og:site_name" content="Google Books"/><meta property="og:image" content="http://www.google.com/patents?id=&amp;printsec=frontcover&amp;img=1&amp;zoom=1"/><link rel="image_src" href="http://www.google.com/patents?id=&amp;printsec=frontcover&amp;img=1&amp;zoom=1"/><script>(function(){try{var aa=function(a,b,c,d){d=d||{};d._sn=["cfg",b,c].join(".");window.gbar.logger.ml(a,d)};var g=window.gbar=window.gbar||{},l=window.gbar.i=window.gbar.i||{},m={},n;function _tvn(a,b){var c=parseInt(a,10);return isNaN(c)?b:c}function _tvf(a,b){var c=parseFloat(a);return isNaN(c)?b:c}function _tvv(a){return!!a}function p(a,b,c){(c||g)[a]=b}g.bv={n:_tvn("2",0),r:"",f:".67.",e:"0",m:_tvn("0",1)};
function q(a,b,c){var d="on"+b;if(a.addEventListener)a.addEventListener(b,c,!1);else if(a.attachEvent)a.attachEvent(d,c);else{var f=a[d];a[d]=function(){var a=f.apply(this,arguments),b=c.apply(this,arguments);return void 0==a?b:void 0==b?a:b&&a}}}var s=function(a){return function(){return g.bv.m==a}},ba=s(1),ca=s(2);p("sb",ba);p("kn",ca);l.a=_tvv;l.b=_tvf;l.c=_tvn;l.i=aa;var da=window.gbar.i.i;var t,u,v,w;function ea(a){v=a}function fa(a){var b;if(b=v&&window.encodeURIComponent)b=a.href,b=!b.match(/^http[s]?:\/\/accounts\.google\.[^/]*\/ClearSID/i)&&!b.match(/^http[s]?:\/\/[^/]*\/accounts\/ClearSID/i);if(b=b&&encodeURIComponent(v()))a.href=a.href.replace(/([?&]continue=)[^&]*/,"$1"+b)}function ga(a){window.gApplication&&(a.href=window.gApplication.getTabUrl(a.href))}
function ha(a){var b=document.forms[0].q,c=window.encodeURIComponent&&b&&b.value,b=b&&b.placeholder;c&&c!=b&&(a.href=a.href.replace(/([?&])q=[^&]*|$/,function(a,b){return(b||"&")+"q="+encodeURIComponent(c)}))}n=l.a("")?ga:ha;
function x(a,b,c,d,f,e){var h=document.getElementById(a);if(h){var k=h.style;k.left=d?"auto":b+"px";k.right=d?b+"px":"auto";k.top=c+"px";k.visibility=u?"hidden":"visible";f&&e?(k.width=f+"px",k.height=e+"px"):(x(t,b,c,d,h.offsetWidth,h.offsetHeight),u=u?"":a)}}
var y=[],ia=function(a,b){y.push(b)},ja=function(a){a=a||window.event;var b=a.target||a.srcElement;a.cancelBubble=!0;null==t&&(a=document.createElement(Array.every||window.createPopup?"iframe":"div"),a.frameBorder="0",t=a.id="gbs",a.src="javascript:''",b.parentNode.appendChild(a),q(document,"click",z));var c=b,b=0;"gb3"!=c.className&&(c=c.parentNode);a=c.getAttribute("aria-owns")||"gbi";var d=c.offsetWidth,f=20<c.offsetTop?46:24;document.getElementById("tphdr")&&(f-=3);var e=!1;do b+=c.offsetLeft||
0;while(c=c.offsetParent);var c=(document.documentElement.clientWidth||document.body.clientWidth)-b-d,h,d=document.body,k=document.defaultView;k&&k.getComputedStyle?(d=k.getComputedStyle(d,""))&&(h=d.direction):h=d.currentStyle?d.currentStyle.direction:d.style.direction;h="rtl"==h;if("gbi"==a){for(d=0;k=y[d++];)k();A(null,window.navExtra);h&&(b=c,e=!0)}else h||(b=c,e=!0);u!=a&&z();x(a,b,f,e)},z=function(){u&&x(u,0,0)},A=function(a,b){var c,d=document.getElementById("gbi"),f=a;f||(f=d.firstChild);
for(;b&&(c=b.pop());){var e=d,h=c,k=f;w||(w="gb2");e.insertBefore(h,k).className=w}},ka=function(a,b,c){if((b=document.getElementById(b))&&a){a.className="gb4";var d=document.createElement("span");d.appendChild(a);d.appendChild(document.createTextNode(" | "));d.id=c;b.appendChild(d)}},la=function(){return document.getElementById("gb_70")},ma=function(){return!!u};p("qs",n);p("setContinueCb",ea);p("pc",fa);p("tg",ja);p("close",z);p("addLink",ka);p("almm",A);p("si",la);p("adh",ia);p("op",ma);var B=function(){},C=function(){},F=function(a){var b=new Image,c=D;b.onerror=b.onload=b.onabort=function(){try{delete E[c]}catch(a){}};E[c]=b;b.src=a;D=c+1},E=[],D=0;p("logger",{il:C,ml:B,log:F});var G=window.gbar.logger;var H={},na={},I=[],oa=l.b("0.1",.1),pa=l.a("1",!0),qa=function(a,b){I.push([a,b])},ra=function(a,b){H[a]=b},sa=function(a){return a in H},J={},K=function(a,b){J[a]||(J[a]=[]);J[a].push(b)},ta=function(a){K("m",a)},L=function(a,b){var c=document.createElement("script");c.src=a;c.async=pa;Math.random()<oa&&(c.onerror=function(){c.onerror=null;B(Error("Bundle load failed: name="+(b||"UNK")+" url="+a))});(document.getElementById("xjsc")||document.getElementsByTagName("body")[0]||
document.getElementsByTagName("head")[0]).appendChild(c)},N=function(a){for(var b=0,c;(c=I[b])&&c[0]!=a;++b);!c||c[1].l||c[1].s||(c[1].s=!0,M(2,a),c[1].url&&L(c[1].url,a),c[1].libs&&m.d&&m.d(c[1].libs))},O=function(a){K("gc",a)},P=null,ua=function(a){P=a},M=function(a,b,c){if(P){a={t:a,b:b};if(c)for(var d in c)a[d]=c[d];try{P(a)}catch(f){}}};p("mdc",H);p("mdi",na);p("bnc",I);p("qGC",O);p("qm",ta);p("qd",J);p("lb",N);p("mcf",ra);p("bcf",qa);p("aq",K);p("mdd","");p("has",sa);
p("trh",ua);p("tev",M);var Q=l.b("0.1",.001),R=0;
function _mlToken(a,b){try{if(1>R){R++;var c,d=a,f=b||{},e=encodeURIComponent,h=["//www.google.com/gen_204?atyp=i&zx=",(new Date).getTime(),"&jexpid=",e("17483"),"&srcpg=",e("prop=22"),"&jsr=",Math.round(1/Q),"&ogev=",e("FzDuU7PZD--qsAS_oYHoCQ"),"&ogf=",g.bv.f,"&ogrp=",e("1"),"&ogv=",e("1407723702.0"),"&oggv="+e("es_plusone_gc_20140723.0_p0"),"&ogd=",e("com"),"&ogc=",e("DEU"),"&ogl=",e("en")];f._sn&&(f._sn="og."+
f._sn);for(var k in f)h.push("&"),h.push(e(k)),h.push("="),h.push(e(f[k]));h.push("&emsg=");h.push(e(d.name+":"+d.message));var r=h.join("");S(r)&&(r=r.substr(0,2E3));c=r;var Aa=window.gbar.logger._aem(a,c);F(Aa)}}catch(Na){}}var S=function(a){return 2E3<=a.length},va=function(a,b){return b};function T(a){B=a;p("_itl",S,G);p("_aem",va,G);p("ml",B,G);a={};H.er=a}l.a("")?T(function(a){throw a;}):l.a("1")&&Math.random()<Q&&T(_mlToken);I.push(["m",{url:"//ssl.gstatic.com/gb/js/scm_7385cc5883250b43a39405734c1bea59.js"}]);g.mcf("c",{});g.sg={c:""};if(l.a("1")){var wa=l.a("");I.push(["gc",{auto:wa,url:"//ssl.gstatic.com/gb/js/abc/gci_91f30755d6a6b787dcc2a4062e6e9824.js",libs:"googleapis.client:plusone:gapi.iframes"}]);var xa={version:"gci_91f30755d6a6b787dcc2a4062e6e9824.js",index:"",lang:"en"};H.gc=xa;var U=function(a){window.googleapis&&window.iframes?a&&a():(a&&O(a),N("gc"))};p("lGC",U);l.a("1")&&p("lPWF",U)};window.__PVT="";if(l.a("1")&&l.a("1")){var V=function(a){U(function(){K("pw",a);N("pw")})};p("lPW",V);I.push(["pw",{url:"//ssl.gstatic.com/gb/js/abc/pwm_45f73e4df07a0e388b0fa1f3d30e7280.js"}]);var W=[],ya=function(a){W[0]=a},za=function(a,b){var c=b||{};c._sn="pw";B(a,c)},Ba={signed:W,elog:za,base:"https://plusone.google.com/u/0",loadTime:(new Date).getTime()};H.pw=Ba;var X=function(a,b){for(var c=b.split("."),d=function(){var b=arguments;a(function(){for(var a=g,d=0,e=c.length-1;d<e;++d)a=a[c[d]];a[c[d]].apply(a,b)})},f=g,e=0,h=c.length-1;e<h;++e)f=
f[c[e]]=f[c[e]]||{};return f[c[e]]=d};X(V,"pw.clk");X(V,"pw.hvr");p("su",ya,g.pw)};function Ca(){function a(){for(var b;(b=e[h++])&&"m"!=b[0]&&!b[1].auto;);b&&(M(2,b[0]),b[1].url&&L(b[1].url,b[0]),b[1].libs&&m.d&&m.d(b[1].libs));h<e.length&&setTimeout(a,0)}function b(){0<f--?setTimeout(b,0):a()}var c=l.a("1"),d=l.a(""),f=3,e=I,h=0,k=window.gbarOnReady;if(k)try{k()}catch(r){da(r,"ml","or")}d?p("ldb",a):c?q(window,"load",b):b()}p("rdl",Ca);var Da={D:1,H:2,da:3,p:4,W:5,M:6,F:7,g:8,ha:9,U:10,L:11,T:12,S:13,N:14,Q:15,P:16,fa:17,w:18,O:19,ga:20,ea:21,u:22,G:23,ja:24,ka:25,ia:26,A:27,j:28,o:29,k:30,ca:31,Z:32,$:33,J:34,K:35,ba:36,aa:37,Y:38,B:39,R:40,v:41,X:42,V:43,h:48,C:49,I:500},Y=[1,2,3,4,5,6,9,10,11,13,14,28,29,30,34,35,37,38,39,40,41,42,43,48,49,500];var Z=l.b("0.001",1E-4),Ea=l.b("1",1),Fa=!1,Ga=!1;if(l.a("1")){var Ha=Math.random();Ha<=Z&&(Fa=!0);Ha<=Ea&&(Ga=!0)}var Ia=Da,$=null;function Ja(){var a=0,b=function(b,d){l.a(d)&&(a|=b)};b(1,"");b(2,"");b(4,"");b(8,"");return a}
function Ka(a,b){var c=Z,d=Fa,f;f=a;if(!$){$={};for(var e=0;e<Y.length;e++){var h=Y[e];$[h]=!0}}if(f=!!$[f])c=Ea,d=Ga;if(d){d=encodeURIComponent;g.rp?(f=g.rp(),f="-1"!=f?f:"1"):f="1";c=["//www.google.com/gen_204?atyp=i&zx=",(new Date).getTime(),"&oge=",a,"&ogex=",d("17483"),"&ogev=",d("FzDuU7PZD--qsAS_oYHoCQ"),"&ogf=",g.bv.f,"&ogp=",d("22"),"&ogrp=",d(f),"&ogsr=",Math.round(1/c),"&ogv=",d("1407723702.0"),"&oggv="+
d("es_plusone_gc_20140723.0_p0"),"&ogd=",d("com"),"&ogl=",d("en"),"&ogc=",d("DEU"),"&ogus=",Ja()];if(b){"ogw"in b&&(c.push("&ogw="+b.ogw),delete b.ogw);var k;f=b;e=[];for(k in f)0!=e.length&&e.push(","),e.push(La(k)),e.push("."),e.push(La(f[k]));k=e.join("");""!=k&&(c.push("&ogad="),c.push(d(k)))}F(c.join(""))}}function La(a){"number"==typeof a&&(a+="");return"string"==typeof a?a.replace(".","%2E").replace(",","%2C"):a}C=Ka;p("il",C,G);var Ma={};H.il=Ma;setTimeout(function(){C(Ia.g)},0);}catch(e){window.gbar&&gbar.logger&&gbar.logger.ml(e,{"_sn":"cfg.init"});}})();
(function(){try{var b=window.gbar.i.i;var c=window.gbar;var f=function(d){try{var a=document.getElementById("gbom");a&&d.appendChild(a.cloneNode(!0))}catch(e){b(e,"omas","aomc")}};c.aomc=f;}catch(e){window.gbar&&gbar.logger&&gbar.logger.ml(e,{"_sn":"cfg.init"});}})();
(function(){try{var a=window.gbar;a.mcf("pm",{p:""});}catch(e){window.gbar&&gbar.logger&&gbar.logger.ml(e,{"_sn":"cfg.init"});}})();
(function(){try{window.gbar.rdl();}catch(e){window.gbar&&gbar.logger&&gbar.logger.ml(e,{"_sn":"cfg.init"});}})();
if (window['_OC_timingAction']) {window['_OC_timingAction']('patents_refpage');}</script><style>#gbar,#guser{font-size:13px;padding-top:1px !important;}#gbar{float:left;height:22px}#guser{padding-bottom:7px !important;text-align:right}.gbh,.gbd{border-top:1px solid #c9d7f1;font-size:1px}.gbh{height:0;position:absolute;top:24px;width:100%}#gbs,.gbm{background:#fff;left:0;position:absolute;text-align:left;visibility:hidden;z-index:1000}.gbm{border:1px solid;border-color:#c9d7f1 #36c #36c #a2bae7;z-index:1001}.gb1{margin-right:.5em}.gb1,.gb3{zoom:1}.gb2{display:block;padding:.2em .5em}.gb2,.gb3{text-decoration:none !important;border-bottom:none}a.gb1,a.gb4{text-decoration:underline !important}a.gb1,a.gb2,a.gb3,a.gb4{color:#00c !important}.gbi .gb3,.gbi .gb2,.gbi .gb4{color:#dd8e27 !important}.gbf .gb3,.gbf .gb2,.gbf .gb4{color:#900 !important}a.gb2:hover{background:#36c;color:#fff !important}#gbar .gbz0l{color:#000 !important;cursor:default;font-weight:bold;text-decoration:none !important}
#gbar { padding:.3em .6em !important;}</style></head><body  topmargin="3" marginheight="3"><div id=gbar><nobr><a onclick=gbar.qs(this);gbar.logger.il(1,{t:1}); class=gb1 id=gb_1 href="https://www.google.com/search?sa=N&tab=tw">Search</a> <a onclick=gbar.qs(this);gbar.logger.il(1,{t:2}); class=gb1 id=gb_2 href="http://www.google.com/search?hl=en&tbm=isch&source=og&sa=N&tab=ti">Images</a> <a onclick=gbar.qs(this);gbar.logger.il(1,{t:8}); class=gb1 id=gb_8 href="http://maps.google.com/maps?hl=en&sa=N&tab=tl">Maps</a> <a onclick=gbar.qs(this);gbar.logger.il(1,{t:78}); class=gb1 id=gb_78 href="https://play.google.com/?hl=en&sa=N&tab=t8">Play</a> <a onclick=gbar.qs(this);gbar.logger.il(1,{t:36}); class=gb1 id=gb_36 href="http://www.youtube.com/results?sa=N&tab=t1">YouTube</a> <a onclick=gbar.logger.il(1,{t:5}); class=gb1 id=gb_5 href="http://news.google.com/nwshp?hl=en&tab=tn">News</a> <a onclick=gbar.logger.il(1,{t:23}); class=gb1 id=gb_23 href="https://mail.google.com/mail/?tab=tm">Gmail</a> <a onclick=gbar.logger.il(1,{t:25}); class=gb1 id=gb_25 href="https://drive.google.com/?tab=to">Drive</a> <a class=gb3 href="http://www.google.com/intl/en/options/" onclick="this.blur();gbar.tg(event);return !1" aria-haspopup=true><u>More</u> <small>&#9660;</small></a><div class=gbm id=gbi><a onclick=gbar.logger.il(1,{t:24}); class=gb2 id=gb_24 href="https://www.google.com/calendar?tab=tc">Calendar</a><a onclick=gbar.qs(this);gbar.logger.il(1,{t:51}); class=gb2 id=gb_51 href="http://translate.google.com/?hl=en&sa=N&tab=tT">Translate</a><a onclick=gbar.logger.il(1,{t:17}); class=gb2 id=gb_17 href="http://www.google.com/mobile/?hl=en&tab=tD">Mobile</a><a onclick=gbar.qs(this);gbar.logger.il(1,{t:10}); class=gb2 id=gb_10 href="http://www.google.com/search?hl=en&tbo=u&tbm=bks&source=og&sa=N&tab=tp">Books</a><a onclick=gbar.logger.il(1,{t:212}); class=gb2 id=gb_212 href="https://wallet.google.com/manage/?tab=ta">Wallet</a><a onclick=gbar.qs(this);gbar.logger.il(1,{t:6}); class=gb2 id=gb_6 href="http://www.google.com/search?hl=en&tbo=u&tbm=shop&source=og&sa=N&tab=tf">Shopping</a><a onclick=gbar.logger.il(1,{t:30}); class=gb2 id=gb_30 href="http://www.blogger.com/?tab=tj">Blogger</a><a onclick=gbar.qs(this);gbar.logger.il(1,{t:27}); class=gb2 id=gb_27 href="http://www.google.com/finance?sa=N&tab=te">Finance</a><a onclick=gbar.qs(this);gbar.logger.il(1,{t:31}); class=gb2 id=gb_31 href="https://plus.google.com/photos?sa=N&tab=tq">Photos</a><a onclick=gbar.qs(this);gbar.logger.il(1,{t:12}); class=gb2 id=gb_12 href="http://www.google.com/search?hl=en&tbo=u&tbm=vid&source=og&sa=N&tab=tv">Videos</a><div class=gb2><div class=gbd></div></div><a onclick=gbar.logger.il(1,{t:66}); href="http://www.google.com/intl/en/options/" class=gb2>Even more &raquo;</a></div></nobr></div><div id=guser width=100%><nobr><span id=gbn class=gbi></span><span id=gbf class=gbf></span><span id=gbe></span><a target=_top id=gb_70 href="https://www.google.com/accounts/Login?service=&continue=http://www.google.com/patents%3Fhl%3Den&hl=en" class=gb4>Sign in</a><div style="display: none"><div class=gbm id=gbd5 aria-owner=gbg5><div class=gbmc><ol id=gbom class=gbmcc></ol></div></div></div></nobr></div><div class=gbh style=left:0></div><div class=gbh style=right:0></div><div role="alert" style="position: absolute; left: 0; right: 0;"><a href="http://www.google.com/patents/us6716251?hl=en&amp;output=html_text" title="Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader."><img border="0" src="http://www.google.com/images/cleardot.gif"alt="Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader."></a></div><div id="guser"><nobr></nobr></div><div style="clear:both;"></div><div id="gb-top-search-box" class="gb-top-search-box-small gb-reset"><table><tr><td class="logo"><a href="http://www.google.com/patents" class="logo-link"><img class="logo-img" src="/intl/en/images/logos/google_logo_41.png" alt="Go to Google Books Home" height="41"/></a></td><td><form action="http://www.google.com/search" name="f" id="vheadf" method="get"><span id="hf"></span><input type="hidden" name="tbm" value="pts"/><input type="hidden" name="tbo" value="1"/><input type="hidden" name="hl" value="en"/><table><tr><td><div class="inputs"><table><tr><td><div class="text-input"><input type="text" name="q" id="vheadq" class="text" maxlength="2048" size="31" value="" title="Search Patents" accesskey="s" autocomplete="off"/><script>window._OC_autoDir &&window._OC_autoDir('vheadq', 'tia-vheadq');</script></div></td><td><div class="submit-input"><input name="btnG" class="submit" type="submit" value=""/></div></td></tr></table></div></td><td class="col-ext-links"><div class="ext-links"><a href="http://www.google.com/advanced_patent_search">&lt;nobr&gt;Advanced Patent Search&lt;/nobr&gt;</a></div></td></tr></table></form></td></tr></table></div><div class="kd-appbar"><h2 class="kd-appname"><a href="/patents">Patents</a></h2><div class="kd-buttonbar left" id="left-toolbar-buttons"><a id="appbar-write-review-link" href=""></a><a id="appbar-view-print-sample-link" href=""></a><a id="appbar-view-ebook-sample-link" href=""></a><a id="appbar-patents-prior-art-finder-link" href="https://www.google.com/patents/related/US6716251"></a><a id="appbar-patents-discuss-this-link" href="http://www.google.com/url?id=lGBlBAABERAJ&amp;q=http://patents.stackexchange.com/redirect/google-patents%3Fpatent%3DUS6716251&amp;usg=AFQjCNEHc_8emK0N4c-5qCjGZfUcroEnPQ" data-is-grant="true"></a><a id="appbar-read-patent-link" href="//docs.google.com/viewer?url=patentimages.storage.googleapis.com/pdfs/US6716251.pdf"></a><a id="appbar-download-pdf-link" href="//patentimages.storage.googleapis.com/pdfs/US6716251.pdf"></a></div><div class="kd-buttonbar right" id="right-toolbar-buttons"></div></div><div id="books-microdata" itemscope=""itemtype="http://schema.org/Book"itemid="http://www.google.com/patents/US6716251" style="display:none"><span itemprop="description">The invention concerns an injection implant for filling up wrinkles, thin lines, skin cracks and scars, for reparative or plastic surgery, aesthetic dermatology, and for filling up gums in dental treatment. The invention concerns the use of biologically absorbable polymer microspheres or microparticles...</span><span itemprop="url">http://www.google.com/patents/US6716251?utm_source=gb-gplus-share</span><span class="main-title" itemprop="name">Patent US6716251 - Implant for subcutaneous or intradermal injection</span><img itemprop="image" src="http://www.google.com/patents?id=&amp;printsec=frontcover&amp;img=1&amp;zoom=1"alt="Patent US6716251 - Implant for subcutaneous or intradermal injection" title="Patent US6716251 - Implant for subcutaneous or intradermal injection"></div><div style="display: none"><ol id="ofe-gear-menu-contents" class="gbmcc"><li class="gbe gbmtc"><a class="gbmt goog-menuitem-content" id="" href="http://www.google.com/advanced_patent_search">Advanced Patent Search</a></li></ol></div><table id="viewport_table" cellpadding="0" style="clear:both" cellspacing="0"><tr><td id="viewport_td"><div class=vertical_module_list_row><div id=intl_patents class=about_content><div id=intl_patents_v><table class="patent-bibdata"><tr><td class="patent-bibdata-heading">Publication number</td><td class="single-patent-bibdata">US6716251 B1</td></tr><tr><td class="patent-bibdata-heading">Publication type</td><td class="single-patent-bibdata">Grant</td></tr><tr><td class="patent-bibdata-heading">Application number</td><td class="single-patent-bibdata">US 09/242,103</td></tr><tr><td class="patent-bibdata-heading">Publication date</td><td class="single-patent-bibdata">Apr 6, 2004</td></tr><tr><td class="patent-bibdata-heading">Filing date</td><td class="single-patent-bibdata">Jun 12, 1998</td></tr><tr><td class="patent-bibdata-heading">Priority date<span class="patent-tooltip-anchor patent-question-icon"data-tooltip-text="The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed."></span></td><td class="single-patent-bibdata">Jun 13, 1997</td></tr><tr><td class="patent-bibdata-heading">Fee status<span class="patent-tooltip-anchor patent-question-icon"data-tooltip-text="The fee status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status or dates listed."></span></td><td class="single-patent-bibdata">Paid</td></tr><tr class="patent-bibdata-list-row "><td class="patent-bibdata-heading">Also published as</td><td><span class="patent-bibdata-value-list"><span class="patent-bibdata-value"><a href="/patents/CA2263361A1">CA2263361A1</a>, </span><span class="patent-bibdata-value"><a href="/patents/CA2263361C">CA2263361C</a>, </span><span class="patent-bibdata-value"><a href="/patents/DE69819694D1">DE69819694D1</a>, </span><span class="patent-bibdata-value"><a href="/patents/DE69819694T2">DE69819694T2</a>, </span><span class="patent-bibdata-value"><a href="/patents/EP0969883A1">EP0969883A1</a>, </span><span class="patent-bibdata-value"><a href="/patents/EP0969883B1">EP0969883B1</a>, </span><span class="patent-bibdata-value"><a href="/patents/US7731758">US7731758</a>, </span><span class="patent-bibdata-value"><a href="/patents/US8414657">US8414657</a>, </span><span class="patent-bibdata-value"><a href="/patents/US20040191323">US20040191323</a>, </span><span class="patent-bibdata-value"><a href="/patents/US20100221684">US20100221684</a>, </span><span class="patent-bibdata-value"><a href="/patents/US20120231046">US20120231046</a>, </span><span class="patent-bibdata-value"><a href="/patents/WO1998056431A1">WO1998056431A1</a></span></span></td></tr><tr class="patent-bibdata-list-row alternate-patent-number"><td class="patent-bibdata-heading">Publication number</td><td><span class="patent-bibdata-value-list"><span class="patent-bibdata-value">09242103, </span><span class="patent-bibdata-value">242103, </span><span class="patent-bibdata-value">US 6716251 B1, </span><span class="patent-bibdata-value">US 6716251B1, </span><span class="patent-bibdata-value">US-B1-6716251, </span><span class="patent-bibdata-value">US6716251 B1, </span><span class="patent-bibdata-value">US6716251B1</span></span></td></tr><tr class="patent-bibdata-list-row "><td class="patent-bibdata-heading">Inventors</td><td><span class="patent-bibdata-value-list"><span class="patent-bibdata-value"><a href="http://www.google.com/search?tbo=p&tbm=pts&hl=en&q=ininventor:%22J%C3%A9r%C3%B4me+Asius%22">Jérôme Asius</a>, </span><span class="patent-bibdata-value"><a href="http://www.google.com/search?tbo=p&tbm=pts&hl=en&q=ininventor:%22Hatem+Fessi%22">Hatem Fessi</a>, </span><span class="patent-bibdata-value"><a href="http://www.google.com/search?tbo=p&tbm=pts&hl=en&q=ininventor:%22Franck+Gouchet%22">Franck Gouchet</a>, </span><span class="patent-bibdata-value"><a href="http://www.google.com/search?tbo=p&tbm=pts&hl=en&q=ininventor:%22B%C3%A9n%C3%A9dicte+Laglenne%22">Bénédicte Laglenne</a>, </span><span class="patent-bibdata-value"><a href="http://www.google.com/search?tbo=p&tbm=pts&hl=en&q=ininventor:%22Elisabeth+Laugier-Laglenne%22">Elisabeth Laugier-Laglenne</a></span></span></td></tr><tr class="patent-bibdata-list-row "><td class="patent-bibdata-heading">Original Assignee</td><td><span class="patent-bibdata-value-list"><span class="patent-bibdata-value"><a href="http://www.google.com/search?tbo=p&tbm=pts&hl=en&q=inassignee:%22Aventis+Pharmaceuticals+Holdings,+Inc.%22">Aventis Pharmaceuticals Holdings, Inc.</a></span></span></td></tr><tr class="patent-bibdata-list-row "><td class="patent-bibdata-heading">Export Citation</td><td><span class="patent-bibdata-value-list"><span class="patent-bibdata-value"><a href="/patents/US6716251.bibtex">BiBTeX</a>, </span><span class="patent-bibdata-value"><a href="/patents/US6716251.enw">EndNote</a>, </span><span class="patent-bibdata-value"><a href="/patents/US6716251.ris">RefMan</a></span></span></td></tr><tr class="patent-internal-links"><td colspan=2><span class="patent-bibdata-value"><a href="#backward-citations">Patent Citations</a> (24),</span> <span class="patent-bibdata-value"><a href="#npl-citations">Non-Patent Citations</a> (4),</span> <span class="patent-bibdata-value"><a href="#forward-citations">Referenced by</a> (41),</span> <span class="patent-bibdata-value"><a href="#classifications">Classifications</a> (34),</span> <span class="patent-bibdata-value"><a href="#legal-events">Legal Events</a> (16)</span> </td></tr><tr><td colspan=2 class="patent-bibdata-external-link-spacer-top"></td></tr><tr class="patent-bibdata-external-link-spacer-bottom"></tr><tr><td colspan=2><span class="patent-bibdata-heading">External Links:&nbsp;</span><span><span class="patent-bibdata-value"><a href="http://www.google.com/url?id=lGBlBAABERAJ&q=http://patft.uspto.gov/netacgi/nph-Parser%3FSect2%3DPTO1%26Sect2%3DHITOFF%26p%3D1%26u%3D/netahtml/PTO/search-bool.html%26r%3D1%26f%3DG%26l%3D50%26d%3DPALL%26RefSrch%3Dyes%26Query%3DPN/6716251&usg=AFQjCNH48yie3FzO74805ryd9ZmIgu3yqw">USPTO</a>, </span><span class="patent-bibdata-value"><a href="http://www.google.com/url?id=lGBlBAABERAJ&q=http://assignments.uspto.gov/assignments/q%3Fdb%3Dpat%26pat%3D6716251&usg=AFQjCNEDCMpawUhSoEzAJLeDX_sY7aNJwQ">USPTO Assignment</a>, </span><span class="patent-bibdata-value"><a href="http://www.google.com/url?id=lGBlBAABERAJ&q=http://worldwide.espacenet.com/publicationDetails/biblio%3FCC%3DUS%26NR%3D6716251B1%26KC%3DB1%26FT%3DD&usg=AFQjCNE6GXdFxgmQ0i2D5wuQ38zuwr6ICw">Espacenet</a></span></span></td></tr><tr class="patent-bibdata-group-spacer"></tr></table><div class="number-and-title"><span class="patent-title"><invention-title mxw-id="PT55233600" lang="EN" load-source="patent-office">Implant for subcutaneous or intradermal injection</invention-title></span><br><span class="patent-number">US 6716251 B1</span></div><div class="patent-section patent-abstract-section"><div class="patent-section-header"><span class="patent-section-title">Abstract</span></div><div class="patent-text"><abstract mxw-id="PA50646192" lang="EN" load-source="patent-office"> <div class="abstract">The invention concerns an injection implant for filling up wrinkles, thin lines, skin cracks and scars, for reparative or plastic surgery, aesthetic dermatology, and for filling up gums in dental treatment. The invention concerns the use of biologically absorbable polymer microspheres or microparticles suspended in a gel. Said suspension is produced either ready-for-use or freeze-dried. The biological absorbability of the microspheres is controlled and enables the production of implants having well defined persistence and deliberately limited to 3 years.</div>
  </abstract></div></div><div class="patent-section patent-drawings-section"><div class="patent-section-header"><span class="patent-section-title">Images<span class="patent-section-count">(6)</span></span></div><div class="patent-drawings-body"><div class="patent-drawings-carousel"><div class="drawings"><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/pages/US6716251-0.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/pages/US6716251-0.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/pages/US6716251-1.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/pages/US6716251-1.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/pages/US6716251-2.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/pages/US6716251-2.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/pages/US6716251-3.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/pages/US6716251-3.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/pages/US6716251-4.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/pages/US6716251-4.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/pages/US6716251-5.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/pages/US6716251-5.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div></div></div><div class="patent-drawings-control patent-drawings-prev"><img class="patent-drawings-button-img" alt="Previous page"src="/googlebooks/images/kennedy/page_left.png"width="21" height="21" /></div><div class="patent-drawings-control patent-drawings-next"><img class="patent-drawings-button-img" alt="Next page"src="/googlebooks/images/kennedy/page_right.png"width="21" height="21" /></div></div></div><div class="patent-post-drawings"></div><div class="patent-section patent-claims-section"><div class="patent-section-header"><span class="patent-section-title">Claims<span class="patent-section-count">(20)</span></span></div><div class="patent-text"><div mxw-id="PCLM8650193" lang="EN" load-source="patent-office" class="claims">
    <claim-statement>What is claimed is: </claim-statement> <div class="claim"> <div num="1" id="US-6716251-B1-CLM-00001" class="claim">
      <div class="claim-text">1. A bioresorbable injectable implant for human administration consisting essentially of:</div>
      <div class="claim-text">bioresorbable microspheres or microparticles suspended in a gel consisting essentially of materials of non-animal origin, </div>
      <div class="claim-text">said microspheres or microparticles consisting of at least one polymer of non-animal origin selected from the group consisting of lactic acid polymers, glycolic acid polymers, and lactic acid-glycolic acid co-polymers. </div>
    </div>
    </div> <div class="claim-dependent"> <div num="2" id="US-6716251-B1-CLM-00002" class="claim">
      <div class="claim-text">2. The injectable implant for human administration, according to <claim-ref idref="US-6716251-B1-CLM-00001">claim 1</claim-ref>, wherein said microspheres or microparticles are present in said gel at a concentration of from 50 to 300 g/l.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="3" id="US-6716251-B1-CLM-00003" class="claim">
      <div class="claim-text">3. The injectable implant for human administration, according to <claim-ref idref="US-6716251-B1-CLM-00001">claim 1</claim-ref>, wherein said microspheres or microparticles are present in said gel at a concentration of from 60 to 200 g/l.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="4" id="US-6716251-B1-CLM-00004" class="claim">
      <div class="claim-text">4. The injectable implant for human administration, according to <claim-ref idref="US-6716251-B1-CLM-00001">claim 1</claim-ref>, wherein said microspheres or microparticles have a mean diameter of from 5 to less than 150 micrometers.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="5" id="US-6716251-B1-CLM-00005" class="claim">
      <div class="claim-text">5. The injectable implant for human administration, according to <claim-ref idref="US-6716251-B1-CLM-00001">claim 1</claim-ref>, wherein said microspheres or microparticles have a mean diameter of from 20 to 80 micrometers.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="6" id="US-6716251-B1-CLM-00006" class="claim">
      <div class="claim-text">6. The injectable implant for human administration, according to <claim-ref idref="US-6716251-B1-CLM-00001">claim 1</claim-ref>, wherein said microspheres or microparticles are bioresorbable within a period of 1 year to 3 years.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="7" id="US-6716251-B1-CLM-00007" class="claim">
      <div class="claim-text">7. The injectable implant for human administration according to <claim-ref idref="US-6716251-B1-CLM-00001">claim 1</claim-ref>, wherein said microspheres or microparticles consists of a polymer selected from the group consisting of poly-L-lactic acid, poly-D-lactic acid and mixtures thereof.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="8" id="US-6716251-B1-CLM-00008" class="claim">
      <div class="claim-text">8. The injectable implant for human administration, according to <claim-ref idref="US-6716251-B1-CLM-00001">claim 1</claim-ref>, wherein said polymer has a molecular mass of between 70,000 and 175,000 Daltons.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="9" id="US-6716251-B1-CLM-00009" class="claim">
      <div class="claim-text">9. The injectable implant for human administration, according to <claim-ref idref="US-6716251-B1-CLM-00001">claim 1</claim-ref>, wherein said polymer has a molecular mass of between 120,000 and 170,000 Daltons.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="10" id="US-6716251-B1-CLM-00010" class="claim">
      <div class="claim-text">10. The injectable implant for human administration, according to <claim-ref idref="US-6716251-B1-CLM-00001">claim 1</claim-ref>, wherein said polylactic acid has an intrinsic viscosity of between 3 and 4 dl/g.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="11" id="US-6716251-B1-CLM-00011" class="claim">
      <div class="claim-text">11. The injectable implant for human administration, according to <claim-ref idref="US-6716251-B1-CLM-00001">claim 1</claim-ref> wherein said polylactic acid has an intrinsic viscosity of between 3.35 and 3.65 dl/g.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="12" id="US-6716251-B1-CLM-00012" class="claim">
      <div class="claim-text">12. The injectable implant for human administration, according to <claim-ref idref="US-6716251-B1-CLM-00001">claim 1</claim-ref>, wherein said polylactic acid has a percentage of residual monomer &lt;0.1%.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="13" id="US-6716251-B1-CLM-00013" class="claim">
      <div class="claim-text">13. The injectable implant for human administration, according to <claim-ref idref="US-6716251-B1-CLM-00001">claim 1</claim-ref>, wherein said polylactic acid has a percentage of residual solvents &lt;0.01%.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="14" id="US-6716251-B1-CLM-00014" class="claim">
      <div class="claim-text">14. The injectable implant for human administration, according to <claim-ref idref="US-6716251-B1-CLM-00001">claim 1</claim-ref>, wherein said gel consists essentially of water and 0.1 to 7.5% by weight carboxymethylcellulose (CMC) or hydroxypropymethylcellulose (HPMC).</div>
    </div>
    </div> <div class="claim-dependent"> <div num="15" id="US-6716251-B1-CLM-00015" class="claim">
      <div class="claim-text">15. The injectable implant for human administration, according to <claim-ref idref="US-6716251-B1-CLM-00001">claim 1</claim-ref>, wherein said gel consists essentially of water and 0.1 to 5.0% by weight carboxymethylcellulose (CMC) or hydroxypropymethylcellulose (HPMC).</div>
    </div>
    </div> <div class="claim"> <div num="16" id="US-6716251-B1-CLM-00016" class="claim">
      <div class="claim-text">16. A bioresorbable injectable implant, free of materials of animal origin, for human administration comprising:</div>
      <div class="claim-text">microparticles, free of materials of animal origin, comprising: </div>
      <div class="claim-text">at least one polymer selected from the group consisting of lactic acid polymers, glycolic acid polymers, lactic acid-glycolic acid co-polymers, and mixtures thereof; and </div>
      <div class="claim-text">a gel, free of materials of animal origin, comprising: </div>
      <div class="claim-text">water for injection, </div>
      <div class="claim-text">from about 0.1 to about 7.5% (wt/wt) of an injectable gelling agent, and </div>
      <div class="claim-text">a surfactant, </div>
      <div class="claim-text">wherein said microparticles are suspended in said gel, and </div>
      <div class="claim-text">wherein said gel is resorbable within about two months. </div>
    </div>
    </div> <div class="claim-dependent"> <div num="17" id="US-6716251-B1-CLM-00017" class="claim">
      <div class="claim-text">17. The bioresorbable injectable implant according to <claim-ref idref="US-6716251-B1-CLM-00016">claim 16</claim-ref>, wherein said gelling agent is a cellulose derivative.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="18" id="US-6716251-B1-CLM-00018" class="claim">
      <div class="claim-text">18. The bioresorbable injectable implant according to claims <b>17</b>, wherein said cellulose derivative is at least one member selected from the group consisting of carboxymethylcellulose and hydroxypropylmethylcellulose.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="19" id="US-6716251-B1-CLM-00019" class="claim">
      <div class="claim-text">19. The bioresorbable injectable implant according to <claim-ref idref="US-6716251-B1-CLM-00016">claim 16</claim-ref>, wherein said gelling agent is synthetic hyaluronic acid.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="20" id="US-6716251-B1-CLM-00020" class="claim">
      <div class="claim-text">20. The bioresorbable injectable implant according to <claim-ref idref="US-6716251-B1-CLM-00016">claim 16</claim-ref>, wherein said surfactant is at least one member selected from the group consisting of polyoxyethylene sorbitan monooleate and polyoxyethylene-polyoxypropylene block copolymer surfactant.</div>
    </div>
  </div> </div></div></div><div class="patent-section patent-description-section"><div class="patent-section-header"><span class="patent-section-title">Description</span></div><div class="patent-text"><div mxw-id="PDES54157913" lang="EN" load-source="patent-office" class="description">
    <heading>REFERENCE TO RELATED APPLICATION</heading> <p>This Application is a 371 of PCT/FR98/01241, filed Jun. 12, 1998, which in turn claims the priority of France 97 07334, filed Jun. 13, 1997.</p>
    <p>The present invention relates to an implant for subcutaneous or intradermal injection, intended to be used in humans in reparative or plastic surgery and in esthetic dermatology, for filling wrinkles, fine lines, skin cracks, acne scars and other scars, as well as in dentistry for filling the gums.</p>
    <p>Up until now, a number of products have been used for this purpose. Each product has advantages and disadvantages.</p>
    <p>Silicone gel (or silicone oil) is easy to use. However, the migration of droplets of silicone into the tissues situated below the point of injection, by simple gravity, has been observed after injection. Silicone is frequently the cause of chronic inflammation, of formation of granulomas, and even of tardive allergic reactions. Silicone is not biodegradable, and it is often found in the liver.</p>
    <p>Teflon paste is a suspension of polytetrafluoroethylene particles (diameter 10 to 100 μm) in glycerine. This product, in numerous cases, caused severe and chronic serous infections and had to be removed after a few months from dermal and subdermal tissues for most patients. It has also been proved that small polytetrafluoroethylene particles were found in the liver.</p>
    <p>Collagen suspensions have been very widely used in the last ten years. The results have however been quite disappointing since collagen is resorbed within 1 to 3 months. Allergic reactions are also noted in about 2% of patients. Finally, it should be noted that collagen is of bovine origin.</p>
    <p>Biological samples from the patient himself: the idea was certainly interesting, but clinical experience has shown the failure of the reimplantation of the fatty cells, which are absorbed and disappear within a few weeks.</p>
    <p>Another system consisted in adding plasma from the patient to a collagen gelatin of bovine and porcine origin. The results are even more disappointing, and the product is of animal origin.</p>
    <p>Hyaluronate gels provided a good alternative by virtue of their biocompatibility and their lack of toxicity. They are moreover widely used in eye surgery. However, their rapid bioresorbability (maximum 2 months) makes them ineffective for use in plastic surgery.</p>
    <p>Bioplastics are polymerized silicone particles (diameter 70 to 140 μm) dispersed in polyvinyl-pyrrolidone. The product had to be withdrawn given the chronic inflammation and the rejection reactions caused by it.</p>
    <p>Polymethyl methacrylate (PMMA) microspheres having a diameter of 20 to 40 μm in suspension either in a solution of gelatin or in a solution of collagen. PMMA is not biodegradable, but not enough time has elapsed in order to know what this implant gives after 5 or 6 years. Moreover, the vector remains a solution of collagen of bovine origin, with the problems of allergy which are known for it.</p>
    <p>The aim of the invention is to overcome the disadvantages of known products.</p>
    <p>The invention uses microspheres or microparticles consisting of a neutral polymer chosen for its innocuousness and which is already widely used by the pharmaceutical industry either by the oral route or by the parenteral route.</p>
    <p>The implant according to the invention combines ease of use without prior manipulations, syringeability of the product, resorbability over a controlled time of the polymer as well as of the vector gel, and absence of allergenicity of the product, which makes any preliminary test unnecessary.</p>
    <p>The microspheres or microparticles should have a controlled bioresorbability offering a resorbability time of between 1 and 3 years. This means that the polymer will be degraded, after injection in situ, into low-molecular-weight compounds which will be eliminated from the body by natural processes. In no case does a non-resorbable implant appear to be desirable. It is still a foreign body placed in a living tissue.</p>
    <p>The microspheres or microparticles are suspended in a gel. They should have a diameter greater than 5 μm and preferably greater than 20 μ, so as not to be absorbed by the macrophages. They should have a diameter of less than 150 μm, and preferably less than 40 μm, so that, on the one hand, they can be injected by a fine needle and, on the other hand, they do not create a granular mass under the finger.</p>
    <p>Two families of polymers essentially meet the preceding definition: the polycaprolactones (and in particular the poly-ε-caprolactones), as well as the polylactides (polylactic acids or PLA), the poly-glycolides (polyglycolic acids or PGA) and their copolymers (polylactic-co-glycolic acids or PLAGA).</p>
    <p>Given the numerous studies already carried out and the good knowledge of the products, in particular as regards the manufacture of microspheres and resorbability, it appears advantageous to use a mixture of polylactic acid (PLA) and polylactic-co-glycolic acid (PLAGA). The proportions of each of these two acids make it possible to determine the persistence of the product.</p>
    <p>Numerous trials have also led to a preference for a polymer consisting of a poly-L-lactic acid (crystalline), a poly-D-lactic acid (amorphous), or a mixture of these two acids. Its molecular mass, calculated by viscometry, is advantageously between 70,000 and 175,000 Dalton, and preferably between 120,000 and 170,000 Dalton, an intrinsic viscosity of between 3 and 4 dl/g, and preferably between 3.35 and 3.65 dl/g, a specific rotation of between −150 and −160°, a melting point of between 178.0 and 190.1° C., a heat of fusion of between 85.0 J/g and 90.0 J/g, a quantity of residual solvents &lt;0.01% and a proportion of residual monomer (lactic acid) &lt;0.1%. Such a product is available from PURAC BIOCHEM in Gorinchem (The Netherlands).</p>
    <p>Bioresorbable synthetic polymers have been studied for about 15 years under the direction of Michel VERT, Director of Research at C.N.R.S. The first clinical uses of PLAs started in 1981 for various indications in facial traumatology. The use of lactic acid polymers has become systematic in the context of bioresorbable surgical implants. PLAs now have diverse and wide medical applications (bone surgery, maxillo-facial surgery, controlled-release pharmacological formulations: implants, microspheres, nanospheres, vaccines).</p>
    <p>The degradation of lactic acid and/or glycolic acid polymers in biological medium occurs exclusively by a chemical mechanism of nonspecific hydrolysis. The products of this hydrolysis are then metabolized and then eliminated by the human body. Chemical hydrolysis of the polymer is complete; the more pronounced its amorphous character and the lower its molecular mass, the more rapidly it occurs. Thus, the resorbability time may be adjusted by acting on the composition of the mixture and/or on the molecular mass of the polymer(s). The biocompatibility of the PLA and PLAGA polymers makes them excellent supports for cellular growth and tissue regeneration.</p>
    <p>The microspheres or microparticles are included in a gel. This gel, which is used as vector to maintain the microspheres or microparticles in a homogeneous suspension, is resorbable within approximately 2 months, which corresponds to the time necessary for the creation of fibroses around the microspheres or microparticles. It consists mainly of water for injection and a gelling agent authorized in injection: cellulose derivatives, and more particularly carboxymethylcellulose (CMC) at a concentration by mass of 0.1 to 7.5%, and preferably from 0.1 to 5.0%. It is also possible to use hydroxypropyl-methylcellulose (HPMC) which is commonly used in intraocular injection in the context of cataract operations. It is also possible to use a synthetic hyaluronic acid, which is used for intraocular injections and subcutaneous injections. It is also possible to use lactic acid esters, caproic acid esters and the like.</p>
    <p>The good dispersion of the microspheres or microparticles and the homogeneity of the gel will be provided by the use of a surfactant chosen for its innocuousness and its authorized subcutaneous and intradermal use. Polyoxyethylene sorbitan monooleate (marketed under the name Tween 80) or pluronic acid will be used.</p>
    <p>The product may be provided in ready-for-use prefilled sterile syringes, provided with a needle, or in vials of sterile suspension. It may also be provided in a vial containing a freeze-dried product accompanied by an ampule of sterile water (water for injection), or in a two-compartment prefilled syringe, one containing the freeze-dried product of microspheres or microparticles, the other containing water for injection.</p>
    <p>The implant does not require a test of allergenicity. It does not contain any product of animal origin.</p>
    <p>The protocol for the manufacture of the implant is described below, in the case of a ready-for-use suspension of microspheres.</p>
    <p>A. Preparation of microspheres of lactic acid polymer. The conventional solvent evaporation technique, or the so-called controlled precipitation technique or any other technique which makes it possible to obtain microspheres of the desired size is used.</p>
    <p>B. Preparation of a gel of sufficient viscosity to maintain the microspheres in suspension. This viscosity will be adjusted depending on the size of the microspheres and the proportion of microspheres dispersed in the gel. This proportion will be from 50 to 300 g/l, and preferably from 60 to 200 g/l.</p>
    <p>C. Distribution of the gel into syringes or into vials, in a controlled atmosphere (class 10<sup>4</sup>).</p>
    <p>D. Sterilization of the vials or syringes, or use of a process which makes the finished product suitable for injection by the subcutaneous route.</p>
    <p>The manufacturing protocol is described below in the case of freeze-dried PLA microparticles, whether this is the L polymer, the D polymer or a mixture thereof.</p>
    <p>A. Cryogrinding of the PLA under gaseous nitrogen filtered at 0.22μm, at a temperature of less than −80° C., on a 100μm screening grid.</p>
    <p>B. Sieving of the microparticles on a 100μm stainless steel sieve.</p>
    <p>C. Preparation of the freeze-drying medium including the dissolution, with stirring, of CMC (gelling agent), of apyrogenic mannitol (cryoprotecting agent), and of polysorbate (surfactant) in water for injection, filtration at 0.22μm of the solution obtained under gaseous nitrogen filtered at 0.22 μm, and sterilization in an autoclave for 20 minutes at 121.5° C.</p>
    <p>D. Distribution of the microparticles at a rate of 100 mg per vial of 4 ml nominal capacity.</p>
    <p>E. Distribution of the freeze-drying medium at a rate of 1.05±0.05 g into the vials already containing the polylactic acid microparticles.</p>
    <p>F. Dispersion of the microparticles in the freeze-drying medium by an ultrasound dispersion system in order to obtain a homogeneous suspension.</p>
    <p>G. Prestoppering of the bottles using pillar stoppers (specific for freeze-drying), rapid freezing below −70° C., storage of the frozen vials below −40° C., and finally freeze-drying and automatic stoppering of the vials.</p>
    <p>H. Fitting of capsules and examination of the vials, before sterilization by γ irradiation.</p>
    <p>Of course, it is possible to combine the procedures described above, for example in order to obtain a suspension of microparticles ready for use, or a freeze-dried product of microspheres, the microparticles or the microspheres consisting of any of the above-mentioned polymers and mixtures thereof.</p>
    <heading>EXAMPLE 1</heading> <p>2 g of PLA are dissolved in 20 ml of an organic solvent (ethyl acetate). This solution is dispersed in 100 ml of water containing 5 g of polyoxyethylene sorbitan monooleate. Moderate vortex stirring is maintained until evaporation of the solvent and formation of microspheres having a mean diameter of 40 μm. The microspheres formed are recovered by sedimentation, filtration and drying. They are then included in a gel consisting of water and CMC (0.5% by mass). After moderate stirring, the distribution is carried out.</p>
    <heading>EXAMPLE 2</heading> <p>2 g of PLA are dissolved in 20 ml of an organic solvent (methylene chloride). This solution is dispersed in 100 ml of water containing 5 g of polyoxyethylene sorbitan monooleate. Moderate vortex stirring is maintained until evaporation of the solvent and formation of microspheres having a mean diameter of 80 μm. The microspheres formed are recovered by sedimentation, filtration and drying. They are then included in a gel consisting of water and CMC (0.5% by mass). After moderate stirring, the distribution is carried out.</p>
    <heading>EXAMPLE 3</heading> <p>2 g of PLA are dissolved in 20 ml of an organic solvent (chloroform). This solution is dispersed in 100 ml of water containing 5 g of polyoxyethylene sorbitan monooleate. Moderate vortex stirring is maintained until evaporation of the solvent and formation of microspheres having a mean diameter of 50 μm. The microspheres formed are recovered by sedimentation, filtration and drying. They are then included in a gel consisting of water and HPMC (1% by mass). After moderate stirring, the distribution is carried out.</p>
    <heading>EXAMPLE 4</heading> <p>600 g of polylactic acid are cryoground to a final particle size of between 20 and 100 μm, with a median at 40 μm. These microparticles are distributed at a rate of 100 mg per vial.</p>
    <p>6.5 kg of freeze-drying medium are manufactured by dissolving 97.5 g of sodium CMC, 276.25 g of apyrogenic mannitol, and 6.5 g of polysorbate 80 in qs 6.5 liters of water for injection. This medium is distributed at a rate of 1 g per vial.</p>
    <p>Trials were carried out on animals (hairless mice and New Zealand rabbits) with the products of Examples 1 to 4. The results are identical, and during the first two months, and from the eighth day after the injection, the appearance of giant cells surrounding in a network the crystals of polylactic acid is observed followed by their transformation by creation of a fibrosis which reconstitutes the subcutaneous tissue.</p>
    </div></div></div><div class="patent-section patent-tabular-section"><a id="backward-citations"></a><div class="patent-section-header"><span class="patent-section-title">Patent Citations</span></div><table class="patent-data-table"><thead class="patent-data-table-thead"><tr class="patent-data-table"><th class="patent-data-table-th">Cited Patent</th><th class="patent-data-table-th">Filing date</th><th class="patent-data-table-th">Publication date</th><th class="patent-data-table-th">Applicant</th><th class="patent-data-table-th">Title</th></tr></thead><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4093576">US4093576</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Apr 5, 1976</td><td class="patent-data-table-td patent-date-value">Jun 6, 1978</td><td class="patent-data-table-td ">Sulzer Brothers, Ltd.</td><td class="patent-data-table-td ">Mixture for anchoring bone implants</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4897267">US4897267</a></td><td class="patent-data-table-td patent-date-value">Jul 28, 1988</td><td class="patent-data-table-td patent-date-value">Jan 30, 1990</td><td class="patent-data-table-td ">Ire-Celltarg S.A.</td><td class="patent-data-table-td ">Microparticles comprising a biodegradable polymer controlling the release of an antimalaria active principle, pharmaceutical compositions comprising it and process for its preparation</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4919929">US4919929</a></td><td class="patent-data-table-td patent-date-value">Sep 17, 1986</td><td class="patent-data-table-td patent-date-value">Apr 24, 1990</td><td class="patent-data-table-td ">Stolle Research &amp; Development Corporation</td><td class="patent-data-table-td ">Inoculating with microencapsulated antigen</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5059123">US5059123</a></td><td class="patent-data-table-td patent-date-value">Oct 18, 1990</td><td class="patent-data-table-td patent-date-value">Oct 22, 1991</td><td class="patent-data-table-td ">Jernberg Gary R</td><td class="patent-data-table-td ">Sustaines drug delivery of chemotherapy agents</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5185152">US5185152</a></td><td class="patent-data-table-td patent-date-value">Aug 13, 1991</td><td class="patent-data-table-td patent-date-value">Feb 9, 1993</td><td class="patent-data-table-td ">Peyman Gholam A</td><td class="patent-data-table-td ">Method and apparatus for controlled release drug delivery to the cornea and anterior chamber of the eye</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5258028">US5258028</a></td><td class="patent-data-table-td patent-date-value">Jun 12, 1991</td><td class="patent-data-table-td patent-date-value">Nov 2, 1993</td><td class="patent-data-table-td ">Ersek Robert A</td><td class="patent-data-table-td ">Plastic surgery, rough microspheres of polydimethylsiloxane in polyvinylpyrrolidone hydrogel</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5288496">US5288496</a></td><td class="patent-data-table-td patent-date-value">May 15, 1990</td><td class="patent-data-table-td patent-date-value">Feb 22, 1994</td><td class="patent-data-table-td ">Stolle Research &amp; Development Corporation</td><td class="patent-data-table-td ">Administering steroid in injectable biodegradable polymer matrix</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5344452">US5344452</a></td><td class="patent-data-table-td patent-date-value">Dec 8, 1989</td><td class="patent-data-table-td patent-date-value">Sep 6, 1994</td><td class="patent-data-table-td ">Martin Lemperle</td><td class="patent-data-table-td ">Alloplastic implant</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5356629">US5356629</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Jul 12, 1991</td><td class="patent-data-table-td patent-date-value">Oct 18, 1994</td><td class="patent-data-table-td ">United States Surgical Corporation</td><td class="patent-data-table-td ">Composition for effecting bone repair</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5451406">US5451406</a></td><td class="patent-data-table-td patent-date-value">Jul 14, 1994</td><td class="patent-data-table-td patent-date-value">Sep 19, 1995</td><td class="patent-data-table-td ">Advanced Uroscience, Inc.</td><td class="patent-data-table-td ">Tissue injectable composition and method of use</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5466462">US5466462</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Mar 22, 1993</td><td class="patent-data-table-td patent-date-value">Nov 14, 1995</td><td class="patent-data-table-td ">Johnson &amp; Johnson Medical, Inc.</td><td class="patent-data-table-td ">Heteromorphic sponges containing active agents</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5470582">US5470582</a></td><td class="patent-data-table-td patent-date-value">Feb 5, 1993</td><td class="patent-data-table-td patent-date-value">Nov 28, 1995</td><td class="patent-data-table-td ">Syntex (U.S.A.) Inc.</td><td class="patent-data-table-td ">Controlled delivery of pharmaceuticals from preformed porous polymeric microparticles</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5478837">US5478837</a></td><td class="patent-data-table-td patent-date-value">Jun 7, 1994</td><td class="patent-data-table-td patent-date-value">Dec 26, 1995</td><td class="patent-data-table-td ">University Of Southern California</td><td class="patent-data-table-td ">Sustained release</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5597897">US5597897</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Jun 22, 1992</td><td class="patent-data-table-td patent-date-value">Jan 28, 1997</td><td class="patent-data-table-td ">Genetics Institute, Inc.</td><td class="patent-data-table-td ">Polymer matrix made from lactic acid and/or glycolic acid for sequestering proteins</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5599852">US5599852</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Oct 18, 1994</td><td class="patent-data-table-td patent-date-value">Feb 4, 1997</td><td class="patent-data-table-td ">Ethicon, Inc.</td><td class="patent-data-table-td ">Polylactone homo- and copolymers</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5977204">US5977204</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Apr 11, 1997</td><td class="patent-data-table-td patent-date-value">Nov 2, 1999</td><td class="patent-data-table-td ">Osteobiologics, Inc.</td><td class="patent-data-table-td ">Biodegradable implant material comprising bioactive ceramic</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP0251695A2?cl=en">EP0251695A2</a></td><td class="patent-data-table-td patent-date-value">Jun 24, 1987</td><td class="patent-data-table-td patent-date-value">Jan 7, 1988</td><td class="patent-data-table-td ">Collagen Corporation</td><td class="patent-data-table-td ">Injectable implant composition having improved intrudability</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP0648480A2?cl=en">EP0648480A2</a></td><td class="patent-data-table-td patent-date-value">Sep 20, 1994</td><td class="patent-data-table-td patent-date-value">Apr 19, 1995</td><td class="patent-data-table-td ">JOHNSON &amp;amp; JOHNSON MEDICAL, INC.</td><td class="patent-data-table-td ">Wound implant materials</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP0711548A1?cl=en">EP0711548A1</a></td><td class="patent-data-table-td patent-date-value">Oct 17, 1995</td><td class="patent-data-table-td patent-date-value">May 15, 1996</td><td class="patent-data-table-td ">Ethicon Inc.</td><td class="patent-data-table-td ">Injectable microdispersions for soft tissue repair and augmentation</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="http://www.google.com/url?id=lGBlBAABERAJ&amp;q=http://worldwide.espacenet.com/publicationDetails/biblio%3FCC%3DFR%26NR%3D2778847A1%26KC%3DA1%26FT%3DD&amp;usg=AFQjCNE53F5eHA6Wgx5fT2EhIcC0iWJidQ">FR2778847A1</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value"></td><td class="patent-data-table-td patent-date-value"></td><td class="patent-data-table-td "> </td><td class="patent-data-table-td citation-no-title">Title not available</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO1993013755A1?cl=en">WO1993013755A1</a></td><td class="patent-data-table-td patent-date-value">Jan 14, 1993</td><td class="patent-data-table-td patent-date-value">Jul 22, 1993</td><td class="patent-data-table-td ">Coletica</td><td class="patent-data-table-td ">Injectable composition containing collagen microcapsules</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO1993015721A1?cl=en">WO1993015721A1</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Feb 5, 1993</td><td class="patent-data-table-td patent-date-value">Aug 19, 1993</td><td class="patent-data-table-td ">William G Hubbard</td><td class="patent-data-table-td ">Soft tissue augmentation material</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO1996033751A1?cl=en">WO1996033751A1</a></td><td class="patent-data-table-td patent-date-value">Apr 25, 1996</td><td class="patent-data-table-td patent-date-value">Oct 31, 1996</td><td class="patent-data-table-td ">Yves Debacker</td><td class="patent-data-table-td ">Injectable hyaluronic acid-containing dual-phase compositions, particularly useful in corrective and plastic surgery</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO1999011196A1?cl=en">WO1999011196A1</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Sep 4, 1998</td><td class="patent-data-table-td patent-date-value">Mar 11, 1999</td><td class="patent-data-table-td ">Point Biomedical Corp</td><td class="patent-data-table-td ">Injectable tissue reconstruction material</td></tr></table><div class="patent-section-footer">* Cited by examiner</div></div><div class="patent-section patent-tabular-section"><a id="npl-citations"></a><div class="patent-section-header"><span class="patent-section-title">Non-Patent Citations</span></div><table class="patent-data-table"><thead class="patent-data-table-thead"><tr class="patent-data-table"><th colspan="3"class="patent-data-table-th">Reference</th></tr></thead><tr><td class="patent-data-table-td ">1</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Beising et al. "<a href='http://scholar.google.com/scholar?q="Mammalian+Response+to+Subdermal+Implantaion+of+Textured+Microimplants%2C"'>Mammalian Response to Subdermal Implantaion of Textured Microimplants,</a>" Aesth. Plast. Surg. pp. 83-90, 1992.*</td></tr><tr><td class="patent-data-table-td ">2</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Costantino et al., "<a href='http://scholar.google.com/scholar?q="Soft-Tissue+Augmentation+and+Replacement+in+the+Head+and+Neck%2C"'>Soft-Tissue Augmentation and Replacement in the Head and Neck,</a>" Otolaryngologic Clinics of N.A., pp. 3,9,11, 1994.*</td></tr><tr><td class="patent-data-table-td ">3</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Ersek et al. "<a href='http://scholar.google.com/scholar?q="Bioplastique%3A+A+New+Biphasic+Polymer+for+Minimally+Invasive+Injection+Implantation%2C"'>Bioplastique: A New Biphasic Polymer for Minimally Invasive Injection Implantation,</a>" Aesth. Plast. Surg. , pp. 59-65, 1992.*</td></tr><tr><td class="patent-data-table-td ">4</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Tom et al, Biotechnol. Prog. (1991), 7 (5), 403-411, (Abstract only).</td></tr></table><div class="patent-section-footer">* Cited by examiner</div></div><div class="patent-section patent-tabular-section"><a id="forward-citations"></a><div class="patent-section-header"><span class="patent-section-title">Referenced by</span></div><table class="patent-data-table"><thead class="patent-data-table-thead"><tr class="patent-data-table"><th class="patent-data-table-th">Citing Patent</th><th class="patent-data-table-th">Filing date</th><th class="patent-data-table-th">Publication date</th><th class="patent-data-table-th">Applicant</th><th class="patent-data-table-th">Title</th></tr></thead><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7731758">US7731758</a></td><td class="patent-data-table-td patent-date-value">Mar 26, 2004</td><td class="patent-data-table-td patent-date-value">Jun 8, 2010</td><td class="patent-data-table-td ">Aventis Pharmaceuticals Holdings, Inc.</td><td class="patent-data-table-td ">Implant for subcutaneous or intradermal injection</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7754233">US7754233</a></td><td class="patent-data-table-td patent-date-value">Sep 3, 2004</td><td class="patent-data-table-td patent-date-value">Jul 13, 2010</td><td class="patent-data-table-td ">Ethicon, Inc.</td><td class="patent-data-table-td ">Placing between the tissues a medical device having as one of its component a fully amorphous copolyester reaction product of a lactone and a polyester of diglycolic acid and ethylene glycol; can be used in a hernia repair mesh</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7767656">US7767656</a></td><td class="patent-data-table-td patent-date-value">Apr 25, 2006</td><td class="patent-data-table-td patent-date-value">Aug 3, 2010</td><td class="patent-data-table-td ">Molly S Shoichet</td><td class="patent-data-table-td ">Blends of temperature sensitive and anionic polymers for drug delivery</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7776840">US7776840</a></td><td class="patent-data-table-td patent-date-value">Feb 21, 2007</td><td class="patent-data-table-td patent-date-value">Aug 17, 2010</td><td class="patent-data-table-td ">Cutanea Life Sciences, Inc.</td><td class="patent-data-table-td ">Repairing vocal chords with chitin and/or chitosan particles; bioresorbable fibrosis stimulating fillers with intermediate lifetimes; avoiding chronic inflammatory reactions and/or rejection</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7910134">US7910134</a></td><td class="patent-data-table-td patent-date-value">Oct 29, 2007</td><td class="patent-data-table-td patent-date-value">Mar 22, 2011</td><td class="patent-data-table-td ">Ayman Boutros</td><td class="patent-data-table-td ">Alloplastic injectable dermal filler and methods of use thereof</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7964211">US7964211</a></td><td class="patent-data-table-td patent-date-value">Jun 3, 2010</td><td class="patent-data-table-td patent-date-value">Jun 21, 2011</td><td class="patent-data-table-td ">Ethicon, Inc.</td><td class="patent-data-table-td ">Semi-crystalline absorbable microspheres</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8307831">US8307831</a></td><td class="patent-data-table-td patent-date-value">Mar 16, 2009</td><td class="patent-data-table-td patent-date-value">Nov 13, 2012</td><td class="patent-data-table-td ">Ethicon, Inc.</td><td class="patent-data-table-td ">Implant systems and methods for treating obstructive sleep apnea</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8318695">US8318695</a></td><td class="patent-data-table-td patent-date-value">Jul 23, 2008</td><td class="patent-data-table-td patent-date-value">Nov 27, 2012</td><td class="patent-data-table-td ">Allergan, Inc.</td><td class="patent-data-table-td ">Tunably crosslinked polysaccharide compositions</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8338375">US8338375</a></td><td class="patent-data-table-td patent-date-value">Dec 29, 2009</td><td class="patent-data-table-td patent-date-value">Dec 25, 2012</td><td class="patent-data-table-td ">Allergan, Inc.</td><td class="patent-data-table-td ">Packaged product</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8338388">US8338388</a></td><td class="patent-data-table-td patent-date-value">May 18, 2010</td><td class="patent-data-table-td patent-date-value">Dec 25, 2012</td><td class="patent-data-table-td ">Allergan, Inc.</td><td class="patent-data-table-td ">Cross-linking of low-molecular weight and high-molecular weight polysaccharides, preparation of injectable monophase hydrogels, polysaccharides and hydrogels obtained</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8357795">US8357795</a></td><td class="patent-data-table-td patent-date-value">Feb 26, 2009</td><td class="patent-data-table-td patent-date-value">Jan 22, 2013</td><td class="patent-data-table-td ">Allergan, Inc.</td><td class="patent-data-table-td ">Hyaluronic acid-based gels including lidocaine</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8394782">US8394782</a></td><td class="patent-data-table-td patent-date-value">Nov 21, 2008</td><td class="patent-data-table-td patent-date-value">Mar 12, 2013</td><td class="patent-data-table-td ">Allergan, Inc.</td><td class="patent-data-table-td ">Polysaccharide gel formulation having increased longevity</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8394783">US8394783</a></td><td class="patent-data-table-td patent-date-value">Apr 4, 2012</td><td class="patent-data-table-td patent-date-value">Mar 12, 2013</td><td class="patent-data-table-td ">Allergan, Inc.</td><td class="patent-data-table-td ">Polysaccharide gel formulation having multi-stage bioactive agent delivery</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8394784">US8394784</a></td><td class="patent-data-table-td patent-date-value">Nov 10, 2009</td><td class="patent-data-table-td patent-date-value">Mar 12, 2013</td><td class="patent-data-table-td ">Allergan, Inc.</td><td class="patent-data-table-td ">Polysaccharide gel formulation having multi-stage bioactive agent delivery</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8414657">US8414657</a></td><td class="patent-data-table-td patent-date-value">May 21, 2012</td><td class="patent-data-table-td patent-date-value">Apr 9, 2013</td><td class="patent-data-table-td ">Valeant International Bermuda</td><td class="patent-data-table-td ">Method for subcutaneous or intradermal injection</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8431141">US8431141</a></td><td class="patent-data-table-td patent-date-value">Apr 30, 2010</td><td class="patent-data-table-td patent-date-value">Apr 30, 2013</td><td class="patent-data-table-td ">Ayman Boutros</td><td class="patent-data-table-td ">Alloplastic injectable dermal filler and methods of use thereof</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8440215">US8440215</a></td><td class="patent-data-table-td patent-date-value">Sep 28, 2007</td><td class="patent-data-table-td patent-date-value">May 14, 2013</td><td class="patent-data-table-td ">Ethicon, Inc.</td><td class="patent-data-table-td ">Absorbable polymer formulations</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8450475">US8450475</a></td><td class="patent-data-table-td patent-date-value">Feb 26, 2009</td><td class="patent-data-table-td patent-date-value">May 28, 2013</td><td class="patent-data-table-td ">Allergan, Inc.</td><td class="patent-data-table-td ">Hyaluronic acid-based gels including lidocaine</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8475815">US8475815</a></td><td class="patent-data-table-td patent-date-value">Oct 29, 2008</td><td class="patent-data-table-td patent-date-value">Jul 2, 2013</td><td class="patent-data-table-td ">Ayman Boutros</td><td class="patent-data-table-td ">Alloplastic injectable dermal filler and methods of use thereof</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8513216">US8513216</a></td><td class="patent-data-table-td patent-date-value">Sep 11, 2009</td><td class="patent-data-table-td patent-date-value">Aug 20, 2013</td><td class="patent-data-table-td ">Allergan, Inc.</td><td class="patent-data-table-td ">Polysaccharide gel formulation having increased longevity</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8556797">US8556797</a></td><td class="patent-data-table-td patent-date-value">Jul 31, 2008</td><td class="patent-data-table-td patent-date-value">Oct 15, 2013</td><td class="patent-data-table-td ">Ethicon, Inc.</td><td class="patent-data-table-td ">Magnetic implants for treating obstructive sleep apnea and methods therefor</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8561616">US8561616</a></td><td class="patent-data-table-td patent-date-value">Oct 24, 2008</td><td class="patent-data-table-td patent-date-value">Oct 22, 2013</td><td class="patent-data-table-td ">Ethicon, Inc.</td><td class="patent-data-table-td ">Methods and devices for the indirect displacement of the hyoid bone for treating obstructive sleep apnea</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8561617">US8561617</a></td><td class="patent-data-table-td patent-date-value">Oct 30, 2008</td><td class="patent-data-table-td patent-date-value">Oct 22, 2013</td><td class="patent-data-table-td ">Ethicon, Inc.</td><td class="patent-data-table-td ">Implant systems and methods for treating obstructive sleep apnea</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8563532">US8563532</a></td><td class="patent-data-table-td patent-date-value">Aug 3, 2012</td><td class="patent-data-table-td patent-date-value">Oct 22, 2013</td><td class="patent-data-table-td ">Allergan Industrie Sas</td><td class="patent-data-table-td ">Cross-linking of low-molecular weight and high-molecular weight polysaccharides, preparation of injectable monophase hydrogels, polysaccharides and hydrogels obtained</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8575301">US8575301</a></td><td class="patent-data-table-td patent-date-value">Nov 30, 2012</td><td class="patent-data-table-td patent-date-value">Nov 5, 2013</td><td class="patent-data-table-td ">Ethicon, Inc.</td><td class="patent-data-table-td ">Absorbable polymer formulations</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8580307">US8580307</a></td><td class="patent-data-table-td patent-date-value">Jun 22, 2006</td><td class="patent-data-table-td patent-date-value">Nov 12, 2013</td><td class="patent-data-table-td ">Ethicon, Inc.</td><td class="patent-data-table-td ">High glass transition temperature absorbable microspheres</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8586562">US8586562</a></td><td class="patent-data-table-td patent-date-value">May 10, 2010</td><td class="patent-data-table-td patent-date-value">Nov 19, 2013</td><td class="patent-data-table-td ">Allergan Industrie, Sas</td><td class="patent-data-table-td ">Fluid compositions for improving skin conditions</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8632488">US8632488</a></td><td class="patent-data-table-td patent-date-value">Dec 15, 2009</td><td class="patent-data-table-td patent-date-value">Jan 21, 2014</td><td class="patent-data-table-td ">Ethicon, Inc.</td><td class="patent-data-table-td ">Fluid filled implants for treating medical conditions</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8678008">US8678008</a></td><td class="patent-data-table-td patent-date-value">Jul 30, 2008</td><td class="patent-data-table-td patent-date-value">Mar 25, 2014</td><td class="patent-data-table-td ">Ethicon, Inc</td><td class="patent-data-table-td ">Methods and devices for forming an auxiliary airway for treating obstructive sleep apnea</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8691279">US8691279</a></td><td class="patent-data-table-td patent-date-value">Mar 21, 2011</td><td class="patent-data-table-td patent-date-value">Apr 8, 2014</td><td class="patent-data-table-td ">Allergan, Inc.</td><td class="patent-data-table-td ">Polysaccharide and protein-polysaccharide cross-linked hydrogels for soft tissue augmentation</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8697044">US8697044</a></td><td class="patent-data-table-td patent-date-value">Oct 7, 2008</td><td class="patent-data-table-td patent-date-value">Apr 15, 2014</td><td class="patent-data-table-td ">Allergan, Inc.</td><td class="patent-data-table-td ">Crossed-linked hyaluronic acid and collagen and uses thereof</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8697057">US8697057</a></td><td class="patent-data-table-td patent-date-value">Feb 16, 2012</td><td class="patent-data-table-td patent-date-value">Apr 15, 2014</td><td class="patent-data-table-td ">Allergan, Inc.</td><td class="patent-data-table-td ">Compositions and soft tissue replacement methods</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8703118">US8703118</a></td><td class="patent-data-table-td patent-date-value">Mar 8, 2012</td><td class="patent-data-table-td patent-date-value">Apr 22, 2014</td><td class="patent-data-table-td ">Allergan, Inc.</td><td class="patent-data-table-td ">Crossed-linked hyaluronic acid and collagen and uses thereof</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8709395">US8709395</a></td><td class="patent-data-table-td patent-date-value">Dec 23, 2011</td><td class="patent-data-table-td patent-date-value">Apr 29, 2014</td><td class="patent-data-table-td ">Ayman Boutros</td><td class="patent-data-table-td ">Method for repairing or replacing damaged tissue</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8783258">US8783258</a></td><td class="patent-data-table-td patent-date-value">Dec 1, 2008</td><td class="patent-data-table-td patent-date-value">Jul 22, 2014</td><td class="patent-data-table-td ">Ethicon, Inc.</td><td class="patent-data-table-td ">Implant systems and methods for treating obstructive sleep apnea</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US20100215702">US20100215702</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Jul 23, 2008</td><td class="patent-data-table-td patent-date-value">Aug 26, 2010</td><td class="patent-data-table-td ">Aqtis Ip Bv</td><td class="patent-data-table-td ">Microparticles comprising pcl and uses thereof</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP1870116A1?cl=en">EP1870116A1</a></td><td class="patent-data-table-td patent-date-value">Jun 21, 2007</td><td class="patent-data-table-td patent-date-value">Dec 26, 2007</td><td class="patent-data-table-td ">Ethicon, Inc.</td><td class="patent-data-table-td ">High glass transition temperature absorbable microspheres</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP1872803A1?cl=en">EP1872803A1</a></td><td class="patent-data-table-td patent-date-value">Jun 21, 2007</td><td class="patent-data-table-td patent-date-value">Jan 2, 2008</td><td class="patent-data-table-td ">Ethicon, Inc.</td><td class="patent-data-table-td ">Semi-crystalline absorbable microspheres</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO2008066382A1?cl=en">WO2008066382A1</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Nov 29, 2007</td><td class="patent-data-table-td patent-date-value">Jun 5, 2008</td><td class="patent-data-table-td ">Cam Aesthetics B V I O</td><td class="patent-data-table-td ">Carboxymethyl cellulose-stabilised tissue filler and its preparation and use</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO2008072839A1?cl=en">WO2008072839A1</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Nov 2, 2007</td><td class="patent-data-table-td patent-date-value">Jun 19, 2008</td><td class="patent-data-table-td ">Kang Seon Cho</td><td class="patent-data-table-td ">Dermal filler composition</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO2010036604A1?cl=en">WO2010036604A1</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Sep 21, 2009</td><td class="patent-data-table-td patent-date-value">Apr 1, 2010</td><td class="patent-data-table-td ">Ethicon, Inc.</td><td class="patent-data-table-td ">Composition and method for treating tissue defects</td></tr></table><div class="patent-section-footer">* Cited by examiner</div></div><div class="patent-section patent-tabular-section"><a id="classifications"></a><div class="patent-section-header"><span class="patent-section-title">Classifications</span></div><table class="patent-data-table"><thead class="patent-data-table-thead"><tr class="patent-data-table"><th class="patent-data-table-th"> </th><th class="patent-data-table-th"> </th></tr></thead><tr><td class="patent-data-table-td ">U.S. Classification</td><td class="patent-data-table-td "><span class="nested-value"><a href="http://www.google.com/url?id=lGBlBAABERAJ&q=http://www.uspto.gov/web/patents/classification/uspc623/defs623.htm&usg=AFQjCNEoAr8t6321S-dcUmO_Vn1Bftf5NA#C623S023580">623/23.58</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=lGBlBAABERAJ&q=http://www.uspto.gov/web/patents/classification/uspc623/defs623.htm&usg=AFQjCNEoAr8t6321S-dcUmO_Vn1Bftf5NA#C623S023750">623/23.75</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=lGBlBAABERAJ&q=http://www.uspto.gov/web/patents/classification/uspc523/defs523.htm&usg=AFQjCNHlewjFSAqumAKv7tl2GRjCWGg-Uw#C523S113000">523/113</a></span></td></tr><tr><td class="patent-data-table-td ">International Classification</td><td class="patent-data-table-td "><span class="nested-value"><a href="http://www.google.com/url?id=lGBlBAABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=A61K0008020000">A61K8/02</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=lGBlBAABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=A61K0008040000">A61K8/04</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=lGBlBAABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=A61L0027180000">A61L27/18</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=lGBlBAABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=A61L0027500000">A61L27/50</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=lGBlBAABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=A61K0009190000">A61K9/19</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=lGBlBAABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=A61L0027580000">A61L27/58</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=lGBlBAABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=A61L0027000000">A61L27/00</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=lGBlBAABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=A61F0002000000">A61F2/00</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=lGBlBAABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=A61K0008850000">A61K8/85</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=lGBlBAABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=A61Q0019000000">A61Q19/00</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=lGBlBAABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=A61Q0019080000">A61Q19/08</a></span></td></tr><tr><td class="patent-data-table-td ">Cooperative Classification</td><td class="patent-data-table-td "><span class="nested-value"><a href="http://www.google.com/url?id=lGBlBAABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=A61K8/025">A61K8/025</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=lGBlBAABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=A61K2800/412">A61K2800/412</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=lGBlBAABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=A61Q19/08">A61Q19/08</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=lGBlBAABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=A61Q19/00">A61Q19/00</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=lGBlBAABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=A61L2400/06">A61L2400/06</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=lGBlBAABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=A61L27/58">A61L27/58</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=lGBlBAABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=A61F2/0059">A61F2/0059</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=lGBlBAABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=A61L27/18">A61L27/18</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=lGBlBAABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=A61K8/85">A61K8/85</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=lGBlBAABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=A61K8/042">A61K8/042</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=lGBlBAABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=A61K2800/91">A61K2800/91</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=lGBlBAABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=A61L27/50">A61L27/50</a></span></td></tr><tr><td class="patent-data-table-td ">European Classification</td><td class="patent-data-table-td "><span class="nested-value">A61L27/18</span>, <span class="nested-value">A61K8/02A</span>, <span class="nested-value">A61Q19/00</span>, <span class="nested-value">A61L27/50</span>, <span class="nested-value">A61Q19/08</span>, <span class="nested-value">A61K8/04A</span>, <span class="nested-value">A61L27/58</span>, <span class="nested-value">A61K8/85</span></td></tr></table><div class="patent-section-footer"></div></div><div class="patent-section patent-tabular-section"><a id="legal-events"></a><div class="patent-section-header"><span class="patent-section-title">Legal Events</span></div><table class="patent-data-table"><thead class="patent-data-table-thead"><tr class="patent-data-table"><th class="patent-data-table-th">Date</th><th class="patent-data-table-th">Code</th><th class="patent-data-table-th">Event</th><th class="patent-data-table-th">Description</th></tr></thead><tr><td class="patent-data-table-td patent-date-value">Aug 9, 2012</td><td class="patent-data-table-td ">AS</td><td class="patent-data-table-td ">Assignment</td><td class="patent-data-table-td "><div class="nested-key-value"><span class="nested-key">Owner name: </span><span class="nested-value">VALEANT INTERNATIONAL BERMUDA, BERMUDA</span></div><div class="nested-key-value"><span class="nested-key">Free format text: </span><span class="nested-value">CHANGE IN NAME AND COUNTRY OF INCORPORATION;ASSIGNOR:VALEANT INTERNATIONAL (BARBADOS) SRL;REEL/FRAME:028757/0052</span></div><div class="nested-key-value"><span class="nested-key">Effective date: </span><span class="nested-value">20120703</span></div></td></tr><tr><td class="patent-data-table-td patent-date-value">Jul 30, 2012</td><td class="patent-data-table-td ">AS</td><td class="patent-data-table-td ">Assignment</td><td class="patent-data-table-td "><div class="nested-key-value"><span class="nested-key">Free format text: </span><span class="nested-value">SECURITY AGREEMENT;ASSIGNORS:VALEAN INTERNATIONAL BERMUDA (FORMERLY KNOWN AS VALEANT INTERNATIONAL (BARBADOS) SRL);VALEANT LABORATORIS INTERNATIONAL BERMUDA (FORMERLY KNOWN AS BIOVAIL LABORATRIES INTERNATIONAL (BARBADOS) SRL);REEL/FRAME:028680/0866</span></div><div class="nested-key-value"><span class="nested-key">Effective date: </span><span class="nested-value">20120703</span></div><div class="nested-key-value"><span class="nested-key">Owner name: </span><span class="nested-value">GOLDMAN SACHS LENDING PARTNERS LLC, NEW YORK</span></div><div class="nested-key-value"><span class="nested-key">Free format text: </span><span class="nested-value">SECURITY AGREEMENT;ASSIGNORS:VALEANT INTERNATIONAL BERMUDA (FORMERLY KNOWN AS VALEANT INTERNATIONAL(BARBADOS) SRL);VALEANT LABORATORIES INTERNATIONAL BERMUDA (FORMERLY KNOWN AS BIOVAIL LABORATORIES INTERNATIONAL (BARBADOS) SRL);REEL/FRAME:028680/0866</span></div></td></tr><tr><td class="patent-data-table-td patent-date-value">Jan 10, 2012</td><td class="patent-data-table-td ">AS</td><td class="patent-data-table-td ">Assignment</td><td class="patent-data-table-td "><div class="nested-key-value"><span class="nested-key">Free format text: </span><span class="nested-value">ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:AVENTIS PHARMACEUTICALS INC.;REEL/FRAME:027507/0569</span></div><div class="nested-key-value"><span class="nested-key">Owner name: </span><span class="nested-value">VALEANT INTERNATIONAL (BARBADOS) SRL, BARBADOS</span></div><div class="nested-key-value"><span class="nested-key">Effective date: </span><span class="nested-value">20111216</span></div></td></tr><tr><td class="patent-data-table-td patent-date-value">Sep 7, 2011</td><td class="patent-data-table-td ">FPAY</td><td class="patent-data-table-td ">Fee payment</td><td class="patent-data-table-td "><div class="nested-key-value"><span class="nested-key">Year of fee payment: </span><span class="nested-value">8</span></div></td></tr><tr><td class="patent-data-table-td patent-date-value">Jan 31, 2011</td><td class="patent-data-table-td ">AS</td><td class="patent-data-table-td ">Assignment</td><td class="patent-data-table-td "><div class="nested-key-value"><span class="nested-key">Owner name: </span><span class="nested-value">AVENTIS PHARMACEUTICALS INC., NEW JERSEY</span></div><div class="nested-key-value"><span class="nested-key">Effective date: </span><span class="nested-value">20051221</span></div><div class="nested-key-value"><span class="nested-key">Free format text: </span><span class="nested-value">MERGER;ASSIGNOR:AVENTIS PHARMACEUTICALS HOLDINGS INC.;REEL/FRAME:025722/0884</span></div></td></tr><tr><td class="patent-data-table-td patent-date-value">Jun 3, 2008</td><td class="patent-data-table-td ">AS</td><td class="patent-data-table-td ">Assignment</td><td class="patent-data-table-td "><div class="nested-key-value"><span class="nested-key">Owner name: </span><span class="nested-value">AVENTIS PHARMACEUTICALS INC., NEW JERSEY</span></div><div class="nested-key-value"><span class="nested-key">Free format text: </span><span class="nested-value">ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:AVENTIS PHARMACEUTICALS HOLDINGS INC.;REEL/FRAME:021043/0369</span></div><div class="nested-key-value"><span class="nested-key">Effective date: </span><span class="nested-value">20051221</span></div><div class="nested-key-value"><span class="nested-key">Free format text: </span><span class="nested-value">ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:AVENTIS PHARMACEUTICALS HOLDINGS INC.;REEL/FRAME:21043/369</span></div><div class="nested-key-value"><span class="nested-key">Owner name: </span><span class="nested-value">AVENTIS PHARMACEUTICALS INC.,NEW JERSEY</span></div></td></tr><tr><td class="patent-data-table-td patent-date-value">Feb 29, 2008</td><td class="patent-data-table-td ">AS</td><td class="patent-data-table-td ">Assignment</td><td class="patent-data-table-td "><div class="nested-key-value"><span class="nested-key">Owner name: </span><span class="nested-value">AVENTIS PHARMACEUTICALS HOLDINGS INC., DELAWARE</span></div><div class="nested-key-value"><span class="nested-key">Free format text: </span><span class="nested-value">ASSET AGREEMENT;ASSIGNOR:AVENTIS (IRELAND) LIMITED;REEL/FRAME:020584/0634</span></div><div class="nested-key-value"><span class="nested-key">Effective date: </span><span class="nested-value">20051222</span></div><div class="nested-key-value"><span class="nested-key">Owner name: </span><span class="nested-value">AVENTIS PHARMACEUTICALS HOLDINGS INC.,DELAWARE</span></div><div class="nested-key-value"><span class="nested-key">Free format text: </span><span class="nested-value">ASSET AGREEMENT;ASSIGNOR:AVENTIS (IRELAND) LIMITED;REEL/FRAME:20584/634</span></div></td></tr><tr><td class="patent-data-table-td patent-date-value">Oct 26, 2007</td><td class="patent-data-table-td ">FPAY</td><td class="patent-data-table-td ">Fee payment</td><td class="patent-data-table-td "><div class="nested-key-value"><span class="nested-key">Year of fee payment: </span><span class="nested-value">4</span></div></td></tr><tr><td class="patent-data-table-td patent-date-value">Oct 26, 2007</td><td class="patent-data-table-td ">SULP</td><td class="patent-data-table-td ">Surcharge for late payment</td><td class="patent-data-table-td "></td></tr><tr><td class="patent-data-table-td patent-date-value">Oct 15, 2007</td><td class="patent-data-table-td ">REMI</td><td class="patent-data-table-td ">Maintenance fee reminder mailed</td><td class="patent-data-table-td "></td></tr><tr><td class="patent-data-table-td patent-date-value">Jul 18, 2006</td><td class="patent-data-table-td ">B1</td><td class="patent-data-table-td ">Reexamination certificate first reexamination</td><td class="patent-data-table-td "><div class="nested-key-value"><span class="nested-key">Free format text: </span><span class="nested-value">THE PATENTABILITY OF CLAIMS 1-20 IS CONFIRMED.</span></div></td></tr><tr><td class="patent-data-table-td patent-date-value">Nov 30, 2004</td><td class="patent-data-table-td ">RR</td><td class="patent-data-table-td ">Request for reexamination filed</td><td class="patent-data-table-td "><div class="nested-key-value"><span class="nested-key">Effective date: </span><span class="nested-value">20041012</span></div></td></tr><tr><td class="patent-data-table-td patent-date-value">Sep 22, 2004</td><td class="patent-data-table-td ">AS</td><td class="patent-data-table-td ">Assignment</td><td class="patent-data-table-td "><div class="nested-key-value"><span class="nested-key">Owner name: </span><span class="nested-value">AVENTIS (IRELAND) LIMITED, IRELAND</span></div><div class="nested-key-value"><span class="nested-key">Free format text: </span><span class="nested-value">ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:AVENTIS PHARMACEUTICALS HOLDINGS INC.;REEL/FRAME:015158/0766</span></div><div class="nested-key-value"><span class="nested-key">Effective date: </span><span class="nested-value">20040914</span></div><div class="nested-key-value"><span class="nested-key">Owner name: </span><span class="nested-value">AVENTIS (IRELAND) LIMITED 18 RIVERWALK, NATIONAL D</span></div><div class="nested-key-value"><span class="nested-key">Free format text: </span><span class="nested-value">ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:AVENTIS PHARMACEUTICALS HOLDINGS INC. /AR;REEL/FRAME:015158/0766</span></div><div class="nested-key-value"><span class="nested-key">Free format text: </span><span class="nested-value">ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:AVENTIS PHARMACEUTICALS HOLDINGS INC.;REEL/FRAME:15158/766</span></div><div class="nested-key-value"><span class="nested-key">Owner name: </span><span class="nested-value">AVENTIS (IRELAND) LIMITED,IRELAND</span></div></td></tr><tr><td class="patent-data-table-td patent-date-value">Aug 26, 2004</td><td class="patent-data-table-td ">AS</td><td class="patent-data-table-td ">Assignment</td><td class="patent-data-table-td "><div class="nested-key-value"><span class="nested-key">Owner name: </span><span class="nested-value">AVENTIS PHARMA LTD., IRELAND</span></div><div class="nested-key-value"><span class="nested-key">Free format text: </span><span class="nested-value">ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:AVENTIS PHARMACEUTICALS HOLDINGS INC.;REEL/FRAME:015053/0623</span></div><div class="nested-key-value"><span class="nested-key">Effective date: </span><span class="nested-value">20040826</span></div><div class="nested-key-value"><span class="nested-key">Owner name: </span><span class="nested-value">AVENTIS PHARMA LTD. 18 RIVERWALK, NATIONAL DIGITAL</span></div><div class="nested-key-value"><span class="nested-key">Free format text: </span><span class="nested-value">ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:AVENTIS PHARMACEUTICALS HOLDINGS INC. /AR;REEL/FRAME:015053/0623</span></div><div class="nested-key-value"><span class="nested-key">Free format text: </span><span class="nested-value">ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:AVENTIS PHARMACEUTICALS HOLDINGS INC.;REEL/FRAME:15053/623</span></div><div class="nested-key-value"><span class="nested-key">Owner name: </span><span class="nested-value">AVENTIS PHARMA LTD.,IRELAND</span></div></td></tr><tr><td class="patent-data-table-td patent-date-value">Feb 21, 2003</td><td class="patent-data-table-td ">AS</td><td class="patent-data-table-td ">Assignment</td><td class="patent-data-table-td "><div class="nested-key-value"><span class="nested-key">Owner name: </span><span class="nested-value">AVENTIS PHARMACEUTICALS HOLDINGS, INC., DELAWARE</span></div><div class="nested-key-value"><span class="nested-key">Free format text: </span><span class="nested-value">ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:BIOPHARMEX HOLDING S.A.;REEL/FRAME:013439/0447</span></div><div class="nested-key-value"><span class="nested-key">Effective date: </span><span class="nested-value">20020515</span></div><div class="nested-key-value"><span class="nested-key">Owner name: </span><span class="nested-value">AVENTIS PHARMACEUTICALS HOLDINGS, INC. 3711 KENNET</span></div></td></tr><tr><td class="patent-data-table-td patent-date-value">Feb 8, 1999</td><td class="patent-data-table-td ">AS</td><td class="patent-data-table-td ">Assignment</td><td class="patent-data-table-td "><div class="nested-key-value"><span class="nested-key">Owner name: </span><span class="nested-value">BIOPHARMEX HOLDING S.A., LUXEMBOURG</span></div><div class="nested-key-value"><span class="nested-key">Free format text: </span><span class="nested-value">ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:ASIUS, JEROME;FESSI, HATEM;GOUCHET, FRANCK;AND OTHERS;REEL/FRAME:009886/0166</span></div><div class="nested-key-value"><span class="nested-key">Effective date: </span><span class="nested-value">19990127</span></div></td></tr></table><div class="patent-section-footer"></div></div><div class="modal-dialog" id="patent-images-lightbox"><div class="patent-lightbox-controls"><div class="patent-lightbox-rotate-controls"><div class="patent-lightbox-rotation-text">Rotate</div><div class="rotate-icon rotate-ccw-icon"></div><div class="rotate-icon rotate-cw-icon"></div></div><div class="patent-lightbox-index-counter"></div><a class="patent-lightbox-fullsize-link" target="_blank">Original Image</a><div class="patent-drawings-control patent-drawings-next"><img class="patent-drawings-button-img"src="/googlebooks/images/kennedy/page_right.png" alt="Next page"width="21" height="21" /></div><div class="patent-drawings-control patent-drawings-prev"><img class="patent-drawings-button-img"src="/googlebooks/images/kennedy/page_left.png" alt="Previous page"width="21" height="21" /></div></div><div class="modal-dialog-content"><div class="patent-lightbox-image-holder"><div class="patent-lightbox-placeholder"></div></div></div></div><script>_OC_initPatentsAtb({image_not_available_html: " Image not available"});</script></div></div></div></td></tr></table><script>(function() {var href = window.location.href;if (href.indexOf('?') !== -1) {var parameters = href.split('?')[1].split('&');for (var i = 0; i < parameters.length; i++) {var param = parameters[i].split('=');if (param[0] == 'focus') {var elem = document.getElementById(param[1]);if (elem) {elem.focus();}}}}})();</script><script>_OC_addFlags({LockSrc:"/books/javascript/lock_8a2b04e7bf975d5171d8e4c0b6365c7a.js", Host:"http://www.google.com/", IsBooksRentalEnabled:1, IsWebstoreDisplayCaseEnabled:1, IsObfuscationEnabled:1, IsBrowsingHistoryEnabled:1, IsWebReaderSvgEnabled:0, IsGeoLayerEnabled:1, IsImageModeNotesEnabled:1, IsCopyMenuItemEnabled:1, IsGiftingEnabled:0, IsWebReaderUniversalPaginatorEnabled:0, IsOfflineBubbleEnabled:1, IsReaderEnabledForPlayRequests:1, IsFutureOnSaleVolumesEnabled:1, IsOfflineRestrictedCopyEnabled:1, IsBooksUnifiedLeftNavEnabled:1, IsRestrictedCopyEnabled:1, IsZipitFolderCollectionEnabled:1, IsEndOfSampleRecommendationsEnabled:1, IsRatingsOnBookcardsEnabled:1, IsAdsDisabled:0, IsIframePageDisplayEnabled:0, IsEmbeddedMediaEnabled:1, IsImageModeAnnotationsEnabled:1, IsMyLibraryGooglePlusEnabled:1, IsImagePageProviderEnabled:0, IsBookcardListPriceSmall:0, IsInternalUser:0, IsBooksShareButtonEnabled:0, IsPreOrdersEnabled:0, IsDisabledRandomBookshelves:0, WebstoreDisplayCasePosition:3});_OC_Run({"enable_p13n":false,"add_vol_to_collection_base_url":"http://www.google.com/patents?op=add\u0026sig=ACfU3U2XGLXtFC_zgwBxfyEvE6xSOrontg\u0026id=lGBlBAABERAJ","remove_vol_from_collection_base_url":"http://www.google.com/patents?op=remove\u0026sig=ACfU3U2GocGFsVfafXVz7suH3CYTNOX3tw\u0026id=lGBlBAABERAJ","logged_in":false,"p13n_save_user_settings_url":"http://www.google.com/patents?op=edit_user_settings\u0026sig=ACfU3U0R36E6g-Dk5nt11Vyu_tpO8gtj2Q","is_cobrand":false,"sign_in_url":"https://www.google.com/accounts/Login?service=\u0026continue=http://www.google.com/patents%3Fhl%3Den\u0026hl=en","is_play_enabled":true}, {"volume_id":"","is_ebook":true,"volumeresult":{"has_flowing_text":false,"has_scanned_text":true,"can_download_pdf":false,"can_download_epub":false,"is_pdf_drm_enabled":false,"is_epub_drm_enabled":false,"download_pdf_url":"http://www.google.com/patents/download/Implant_for_subcutaneous_or_intradermal.pdf?id=lGBlBAABERAJ\u0026output=pdf\u0026sig=ACfU3U0hAohT1Bm0xNxoBl766NW1PEnfxg"},"sample_url":"http://www.google.com/patents/reader?id=lGBlBAABERAJ\u0026printsec=frontcover\u0026output=reader\u0026source=gbs_atb_hover","is_browsable":true,"is_public_domain":true}, {});</script><div id="footer_table" style="font-size:83%;text-align:center;position:relative;top:20px;height:4.5em;margin-top:2em"><div style="margin-bottom:8px"><a href=http://www.google.com/><nobr>Google&nbsp;Home</nobr></a> - <a href=//www.google.com/patents/sitemap/><nobr>Sitemap</nobr></a> - <a href=http://www.google.com/googlebooks/uspto.html><nobr>USPTO Bulk Downloads</nobr></a> - <a href=/intl/en/privacy/><nobr>Privacy Policy</nobr></a> - <a href=/intl/en/policies/terms/><nobr>Terms of Service</nobr></a> - <a href=https://support.google.com/faqs/answer/2539193?hl=en><nobr>About Google Patents</nobr></a> - <a href="http://www.google.com/tools/feedback/intl/en/error.html" onclick="try{_OC_startFeedback({productId: '72792',locale: 'en'});return false;}catch(e){}"><nobr>Send Feedback</nobr></a></div><span>Data provided by IFI CLAIMS Patent Services</span><br><span >&copy;2012 Google</span></div> <script type="text/javascript">var gaJsHost = (("https:" == document.location.protocol) ? "https://ssl." : "http://www.");document.write(unescape("%3Cscript src='" + gaJsHost + "google-analytics.com/ga.js' type='text/javascript'%3E%3C/script%3E"));</script><script type="text/javascript">var pageTracker = _gat._getTracker("UA-27188110-1");pageTracker._setCookiePath("/patents/");pageTracker._trackPageview();</script> </body></html>